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ABSTRACT 
 
Migration of encephalitogenic T cells into the brain parenchima through the blood–brain 
barrier (BBB) is a crucial feature for initiating tissue injury in different neuroinflammatory 
diseases [1] [2]. The BBB is comprised of astrocyte processes and endothelial cells, 
which form the lumen of the brain microvasculature and help in maintaining immune 
quiescence through contact-dependent mechanisms as well as release of soluble 
factors [3] [4-6]. Activated CD4+ T cells may establish physical contacts with astrocytes, 
thereby reciprocally influencing cellular activity and functions. In addition, astrocytes and 
CD4 T cells may communicate through the secretion of soluble signaling molecules 
during contact. Among molecules secreted by astrocyte, ATP is a key messenger which 
can also signal to CD4 T cell through purinergic P2 receptors. Our results show that 
activated CD4+ T cells inhibit calcium oscillations in astrocytes through direct 
modulation of extracellular ATP levels. This effect correlated with the expression of 
plasma membrane ectonucleoside triphosphate diphosphohydrolase CD39, which is 
induced by contact of the activated T cell with astrocyte. In addition, T cell contact with 
astrocyte results in the upregulation of the ecto-5‘-nucleotidase CD73, which converts 
AMP to adenosine. This effect was peculiar of T cell contact with astrocyte since it did 
not occur with microglia or peritoneal macrophages. Pharmacological inhibition of Ca2+ 
oscillations in astrocyte completely prevented CD73 induction on T cell, thus suggesting 
that a gliostrasmitter released by astrocyte in a Ca2+-dependent fashion might be 
responsible of this effect. Since degradation of ATP to adenosine by CD73 regulates 
BBB permeability and leukocytes infiltration into the brain [7] [8] this regulatory circuit 
might have important pathogenetic implications in multiple sclerosis and other 
neuroinflammatory conditions. Finally, functional characterization of T cell upon contact 
with astrocyte allowed us to assess a proinflammatory phenotype and Th17 skewing 
albeit with important differences, such as CD39 and CD73 expression, with respect to 
conventionally activated cells. Thus, we characterized an astrocyte specific signature of 
T cell activation, which might be important in the pathogenesis of neuroinflammatory 
disorders. 
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INTRODUCTION 
 
1.1  Adaptive immunity. A general overview 
Adaptive immunity, also called acquired immunity, can be divided into humoral and cell-
mediated immunity. The effector phase of humoral immunity, which is characterized by 
B lymphocytes as the main players, is triggered by the recognition of antigen by 
secreted antibodies; therefore, humoral immunity neutralizes and eliminates 
extracellular microbes and toxins that are accessible to antibodies, but it is not effective 
against microbes inside cells. In contrast, in cell-mediated immunity, the effector phase 
is initiated by the recognition of antigens by T cells. T lymphocytes recognize protein 
antigens as pathogens-derived peptides on the surfaces of infected cells in the context 
of major histocompatibility complex (MHC). Differently from innate immunity, adaptive 
immunity is characterized by somatic-rearrangement of antigen receptor genes, which 
confers clonality, high specificity and memory to the immune response [9]. In health, 
both humoral and cell-mediated immunity play important roles in immune surveillance 
and maintenance of tissue homeostasis, while in pathologic conditions, they work 
cooperatively to clear pathogens and form immunological memory [9]. It is well 
established that T lymphocytes with multiple specificities are generated in the thymus 
before antigen exposure. Naive T lymphocytes circulate throughout the body in a resting 
state, and only after T cell receptor (TCR) triggered activation, they acquire powerful 
effector potential. Naive T lymphocytes activation occurs in specialized lymphoid 
organs, where the naive lymphocytes and antigen presenting cells (APCs) are brought 
together. Protein antigens that cross epithelial barriers or derived from tissues are 
captured by dendritic cells (DC) (the most efficient APCs) and transported to lymph 
nodes. Antigens that enter the circulation may be captured by dendritic cells in the 
spleen. When a naive T cell is stimulated through its TCR by the cognate antigens 
bound to self MHC on an APCs, it receives concomitant costimulatory signals 
indispensable for full activation. After activation, a T cell proliferates, expands, and 
elicits effector functions either by cell-cell contact or cytokine release [9]. Whereas naive 
cells are activated mainly in lymphoid organs, differentiated effector cells may function 
also peripherally in tissues. The process of differentiation from naive to effector cells is 
associated with acquisition of the capacity to perform specialized functions and 
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competence to migrate to the site of infection or inflammation. At these sites, effectors 
cells respond to eliminate the source of the pathogen-derived antigens or provide 
immunregulatory functions to limit inflammation and consequent tissue damage.  
 
1.2 CD4+ T cell subsets 
According to different phenotypes and functions, T cells are divided into two main 
populations, the CD4+ T helper (Th) and CD8+ cytotoxic T cells, which recognize 
antigens in the context of class II and class I MHC, respectively. CD4+ T cell-mediated 
immune reactions are essentially elicited by dendritic cells. Microbial antigens are 
internalized into vesicles by the DCs, processed, and presented in association with 
class II MHC molecules to CD4+ T cells. As mentioned above, the complete activation 
of naive T cells requires costimulatory signals. The best characterized costimulatory 
pathway in T cell activation involves the T cell surface receptor CD28, which binds the 
costimulatory molecules B7-1 (CD80) and B7-2 (CD86) expressed on activated APCs. 
Cytokines also play critical roles in adaptive immune responses; the most important 
cytokine produced by T cells early after activation, is interleukin-2 (IL-2), a growth, 
survival and differentiation factor for T lymphocytes.  
CD4+ T cells can be subdivided into conventional and regulatory T (Tregs) cells, this 
second group comprises natural and adaptively induced Tregs and provide 
immunosuppressive signals to limit inflammation [10].  Depending on the 
microenvironment and the functional status of the APC, naïve CD4+ T cells (Th0) can 
expand and differentiate into different subtypes, which are classified according to the 
cytokine profile and effector functions. As shown in figure 1, the three major subsets of 
conventional effector CD4+ T cells are Th1 (expressing IL-2, IFN-γ, and TNF-α), Th2 
(expressing IL-4, IL-5, and IL-13), and Th17 (expressing IL-17 and IL-22) cells [11, 12] 
[13]. The relatively recent discovery of the IL-17 producing Th17 lineage, has changed 
our previous understanding of T cell responses based on the Th1/Th2 paradigm, which 
considered the Th1 and Th2 lineages as mutually exclusive and regulated by the 
antagonistic activity of Th1 and Th2 cell-derived cytokines [14]. Th17 cells are important 
in the pathogenesis of many inflammatory diseases, such as psoriasis, inflammatory 
bowel disease, rheumatoid arthritis, and multiple sclerosis (MS). Th1 and Th17 cells 
may both be present in the lesions of these diseases, and their respective contribution 
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to the development and propagation of the pathologic condition is an area of intense 
research. Conversely, CD4+ Tregs characterized by expression of the alpha chain of IL-
2 receptor (CD25) and the transcription factor Foxp3, are pivotal in controlling peripheral 
tolerance to self antigens. [15]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The differentiation and regulation of CD4+ T cell subsets. Naive T cells primed by antigen-
presenting cells (APCs) such as dendritic cells (DCs) can differentiate into T regulatory-1 (Tr1)/T helper 
type 3 (Th3), Th1, Th2 or Th17 cells depending upon the cytokine environment. Priming in the presence 
of interleukin (IL)-10 /transforming growth factor (TGF)-b, IL-12, IL-4 or combinations of IL-6/IL-1/IL-23 
promotes the differentiation of Tr1/Th3, Th1, Th2 or Th17 cells, respectively. Th17 cells can be negatively 
regulated by Th1 or Th2 cells. Natural regulatory T cells (Treg) cells are derived from the thymus 
(although they may also be converted in the periphery) and can suppress effector T cell responses 
directly or via the APC [16] 
 
 
1.3.1 Blood brain barrier: the “immune privilege” point of view 
 
In the late 19th century Paul Ehrlich observed that water-soluble vital dyes injected into 
the peripheral circulation would stain all organs except the brain, this experiment 
provided the first indication that the central nervous system (CNS) was anatomically 
separated from the rest of the body. Subsequent studies by Edwin Goldmann, showing 
that dye injected into the spinal fluid did not stain peripheral tissues, confirmed the idea 
that the brain was a unique anatomical compartment. Consequently, the CNS was 
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regarded as an ―immune privileged‖ organ. The main reason for this definition was 
attributable to the existence of the blood-brain barrier (BBB) surrounding the brain 
parenchima. The lack of an obvious lymphatic system, low constitutive levels of MHC 
class I and II molecules, local CNS production of suppressive factors and, in the normal 
state, limited numbers of APCs reinforced the concept of the CNS as an ―immune-
privileged‖ site [17, 18]. Structurally, the BBB is composed of specialized endothelial 
cells (ECs) held together by multiprotein complexes known as junctional proteins [19] 
[3]. BBB limits the transport of specific factors and solutes, including >98% of antibodies 
and small molecules, into the brain parenchyma, while ensuring the efflux of others [16] 
[20]. Astrocytes, which are closely apposed to the CNS vasculature (figure 2), also help 
in maintaining BBB integrity and immune quiescence through contact-dependent 
mechanisms and by releasing soluble factors [3] [4-6].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Cellular constituents of the blood–brain barrier. The barrier is formed by capillary 
endothelial cells, surrounded by basal lamina and astrocytic perivascular endfeet. The figure also shows 
pericytes and microglial cells 
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1.3.2 Trafficking of CD4+ T lymphocytes into the brain 
 
Only very recently the concept of the brain as ―immune privileged‖ site has been revised 
[18] [21]. Indeed, it is becoming more and more clear that whereas few T lymphocytes 
patrol the brain for immune surveillance and are indispensable for brain homeostasis 
[21] under injurious or disease conditions, more T but not B cells infiltrate the brain at 
site of injury [1] [2]. Cells of immune system have access to three distinct brain 
anatomical compartments (i.e., cerebrospinal fluid [CSF], meninges, and parenchyma). 
The migration of leukocytes to the CSF is thought to occur through the choroid plexus 
and the subarachnoid space (which contains the CSF), while the direct migration from 
the blood into the brain parenchyma occurs across the BBB via the perivascular space 
(figure 3). It is important to note that leukocyte recruitment is cell- and site-specific, thus 
infiltration is not likely due to massive disruption of the BBB [1] [2]. Following injury to 
the CNS in fact, the activation of endothelial cells and associated cells as astrocytes 
lead to reduced tight junction integrity and formation of transendothelial cell channels 
[22-24], which facilitate the migration of leukocytes across the BBB [20, 25, 26]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The structure of the brain and routes of leukocyte entry. Beneath the skull lie three 
membranes that enclose the parenchyma of the brain: the dura mater, the arachnoid membrane, and the 
pia mater. The latter two enclose the subarachnoid space. (i) Leukocytes can enter across the choroid 
plexus, where CSF is produced by the choroid plexus epithelium in the ventricles. CSF containing 
leukocytes then enters the subarachnoid space, circulates around the brain, and (ii) exits via the venous 
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sinus to be resorbed by the blood via the arachnoid villi. (iii) Blood supply to the brain enters in the 
subarachnoid space over the pia mater, generating the perivascular space (or Virchow-Robin space). 
Main arterial branches divide into capillaries, which terminate deep within the brain, supplying the 
parenchyma with blood. Leukocytes can potentially enter from the blood (iii), which requires them to cross 
the tightly regulated vascular endothelium (i.e., the BBB: the glia limitans, the subarachnoid space, and 
the pia mater). Cells can adhere to the endothelium and arrest at any point during this process.[27] 
 
 
During CNS entry, activated T cells upregulate many integrins and adhesion molecules, 
enabling their rolling and adhesion to vessel walls. On the other side, circulating and 
CNS-resident cells express and upregulate multiple integrins, chemokines and adhesion 
molecules which participate to infiltration process. Among them, the adhesion molecule 
P-selectin, the vascular cell adhesion molecule 1 (VCAM1) and the intercellular 
adhesion molecule (ICAM1), which bind to very late antigen-4 (VLA-4, also known as 
α4β1 integrin) and lymphocyte function–associated-1 (LFA-1), respectively [28, 29]; and 
the chemokines CCL19 and CCL20 [29-31]. Interestingly, blockade of VLA-4/VCAM1 
interactions delayed the onset and/or decreased the severity of experimental 
autoimmune encephalomyelitis (EAE), a model of the neuroinflammatory disease  
multiple sclerosis [32]. The observation led to the clinical development of a monoclonal 
antibody (known as natalizumab) that targets α4 integrin (a component of VLA-4). 
Natalizumab has been successfully used in clinical trials to manage the disease [33]. 
After rolling along, adhering to, and finally crossing the endothelial cells of the BBB and 
their associated basement membrane, the migrating leukocytes reach their next barrier, 
the glia limitans. Figure 4 shows that this structure surrounds the blood vessel, and is 
composed of astrocytic foot processes. Only in the past few years a dialogue between 
peripheral immunity and the CNS has been appreciated [34] [1, 35]. It is now clear that 
the two systems interplay during physiological condition and in pathological situation. 
The focus of my project was to characterize the molecular basis and functional 
significance underlying the interaction between astrocytes and CD4+ T lymphocytes, 
two of the main critical players belonging to nervous and immune system.  
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Figure 4: Leukocyte trafficking across the glia limitans into the parenchyma of the brain.  Activated 
leukocytes expressing adhesion molecules and integrins roll and attach to the vascular endothelium. 
Successful diapedesis requires appropriate ligation of adhesion molecules, selectins, and integrins, 
signaling to both the infiltrating leukocyte and the brain endothelium. Expression of CXCL12 on the 
basolateral surface of endothelial cells recruits CXCR4+ T cells. However, retention of cells in the 
perivascular space occurs in the presence of high concentrations of CXCL10. Continued migration puts 
cells in contact with the glia limitans, which is composed of a highly structured wall of astrocytes. Further 
positive migratory signals, including chemokines, from these and surrounding cells may allow leukocyte 
migration into the parenchyma. [27]. 
 
 
1.3.3 Astrocytes cross-talk with CD4+ T cells at the BBB and into the parenchima 
Independently from effects mediated by endothelial cells, astrocytes may establish 
direct physical contacts with immune cells within the BBB, thereby directly influencing T 
cell activity. Previous studies have investigated whether an immunological synapses 
(IS) may be formed between astrocytes and activated CD4+ T cells [36]. While surface 
expression of MHC class II molecules was unequivocally reported in astrocytes in 
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response to the cytokine IFN-gamma [37], conflicting results have been published about 
the expression of the co-stimulatory molecules ([38, 39] and our unpublished data), 
which are required to form an IS and to initiate Ag-specific immune response [40]. Thus, 
it is unlikely that a true IS can be established between astrocytes and activated CD4+ T 
cells, especially in vivo, where MHC class II expression is highly debated. However, 
other types of adhesive contacts may be formed between astrocytes and T cells during 
BBB entry, which may reciprocally influence the activity of the two cells. In addition, 
astrocytes and CD4+ T cells may reciprocally communicate through secretion of 
signaling molecules during contact. In this regard, notably, both T cells and astrocytes 
express proteins of the connexin and pannexin families (Cx32, Cx43, Cx30, pannexin1), 
which form membrane hemichannels that mediate release of signalling molecules into 
the pericellular space [41-44]. Through formation of intercellular channels, called gap 
junction, connexins also allow the direct transfer of signaling molecules between 
adjacent cells including cAMP, Ca2+, adenosine-5-triphosphate (ATP), inositol 1,4,5- 
trisphosphate and morphogens [45]. Finally it was discovered that beta1 integrin plays 
an important role not only in the epithelial/T-cell, but also in astrocyte/T cell interaction 
[46-49]. The group of Colombatti discovered that alfa3beta1 integrins are active 
components of the molecular complex mediating astrocyte / T-cell binding [48] and 
another group showed that the subunits of VLA-4 integrin, alfa4beta1, are necessary for 
T cell contact-induced generation of proinflammatory molecules in astroglia [46-49]. 
In conclusion astrocyte and T cell can interact hypothetically through multiple 
mechanisms, but the significance and the final effect underling their interplay is far to be 
completely understood. 
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2.1.1 Physiological functions of astrocytes  
Astrocytes are the most abundant glial cells, within the CNS. They are of 
neuroectodermal origin and they owe their name to the star-like shape (ancient Greek 
αστρον: star, and  κστύος: cell). Indeed  astrocytes display several thin processes, 
through which they contact neurons, blood vessels and other astrocytes. In the late 
nineteenth century and the early twentieth century Camillo Golgi and Ramon y Cajal 
had already noticed that although all astrocytes share a stellate shape (figure 5, left), 
their morphology is extremely diverse in different areas of the brain (Figure 5 A-B). 
Morphological diversity of astrocytes was subsequently confirmed by studies performed  
both in vitro and in vivo [50, 51]. 
 
 
 
Figure 5: Morphological heterogeneities in human cortical astrocytes. (Left) Neuroglia from the 
hippocampal formation (stratum radiatum of the Ammon horn) of a human brain. In this drawing Cajal 
shows astrocytic processes embracing pyramidal neurons as well as astrocytic processes in contact with 
blood vessels. Form Legado Caljal- in: GarcAa Segura 2002. (A) Shows the GFAP immunolabelling of all 
layers of the human temporal cortex; different morphologies of astrocytes that reside at different depth in 
the brain are visible. Scale bar, 150 μm. (B) shows -on the left- schematic representations of classes of 
astrocytes located within the cortex; -on the right- the cortical layers. Primate-specific interlaminar 
astrocytes (light blue) located in layer 1 send long fibers throughout the cortex terminating in layers 3 and 
4. Protoplasmic astrocytes (dark blue; shown here in layers 2 and 4) characteristically inhabit layers 2–6. 
These astrocytes, which vary markedly in size, are organized into domains associated with neurons and 
blood vessels (red). Polarized astrocytes (pink), found in layers 5–6 rather than near the pia, also extend 
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long, but various processes. Fibrous astrocytes (green) reside in the white matter (WM) and are not 
organized into domains. Scale bar 100 μm.  
 
Astrocytes are distinguished by the expression of glial fibrillary acidic protein (GFAP), a 
protein which compose intermediate filaments in their cytoplasm and that is used today 
as an astrocytic marker [52].  Astrocytes are extensively coupled by gap junctions. The 
cellular network created by adjacent astrocytes is called the astrocytic ‗syncytium‘ [53]. 
Although astrocytes form a highly interconnected network, they occupy separate 
domains of the parenchyma, with very limited or no overlap between the region 
occupied by one astrocyte and the regions occupied by its neighboring cells [54, 55]. 
Traditionally astrocytes were regarded as supportive cells with the main task  to 
maintain the physiological homeostasis of neurons by taking up excess 
neurotransmitters and buffering the ionic content of the extracellular medium in the 
brain. However, studies of the last 20 years have shown that astrocytes exert a series of 
complex and different functions  and are involved in almost everything the CNS does. In 
fact, astrocytes assist  synapse formation and function, by stimulation of neurite growth 
and branching, modulation of synaptic transmission and plasticity [56, 57] [58, 59] [60] 
[61]. Furthermore astrocytes, regulate the BBB permeability, myelination of axons and 
participate in the development of the nervous system  [62-67]. The relevance of 
astrocytes as active components of synaptic transmission is highlighted by the term  
―tripartite synapse‖ (figure 6), which indicates a synaptic structure composed of the 
astrocyte wrapped around the synapse as well as the presynaptic and postsynaptic 
terminals [68]. Given the crucial role of astrocytes in brain development, metabolism, 
and function, it is not surprising that astrocytes are involved in almost every disease 
affecting the CNS. 
 
Figure 6: The electron microscopy (EM) of the tripartite 
synapse. The intimate association of astrocytes and 
synapses is both structural and functional. Here is shown a 
tripartite synapse in the hippocampus. The astrocyte 
process (blue) unsheathes the perisynaptic area. The axon 
of the neuron is shown in green, with the dendritic spine in 
yellow and the postsynaptic density in red and black.  
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2.1.2 Astrocytes display both detrimental and protective roles 
 
During neuroinflammation, astrocytes seem to have both detrimental and protective 
activities. They can produce various pro- and anti-inflammatory cytokines, including IL-
1, IL-6, IL-10, IL-12, IL-15, IL-23, IL-27, IL-33, IFN-a, IFN-b, TGF-b, TNF and several 
chemokines, including CCL2 (MCP-1), CCL3, CCL4, CCL5, CCL20, CCL5 (RANTES), 
CXCL8 (IL-8), CXCL10 (IP-10) and CXCL12 (SDF-1) [39]. The ability of astrocytes to 
release in vitro a wide variety of proinflammatory chemokines and cytokines, suggests 
that they may act as proinflammatory mediators [39] [69]. Nevertheless, equally strong 
in vitro evidences suggest that astrocytes may serve to mitigate or restrict inflammation 
by producing anti-inflammatory cytokines and ROS scavengers [39] [70] [71].  
During CNS injury or inflammation, astrocytes upregulate GFAP protein in a process 
termed ―reactive astrocytosis‖, eventually leading to the formation of the so called 
―astroglial scar‖ [72]. The astrogliotic scar can prevent neural stem cell migration into 
the lesion, thus impairing remyelination and axonal regeneration. However, reactive 
astrocytosis may be also beneficial in neuroinflammatory diseases such as MS. 
Notably, as shown in figure 7, experimental autoimmune encephalomyelitis (EAE), the 
widely characterized model of human MS [73], is more severe in GFAP-deficient mice, 
with strongly enhanced immune cell infiltration [74, 75]. Consistent with these data, a 
recent study showed that inhibition of reactive astrocytosis after initiation of EAE leads 
to increased macrophages infiltration and enhanced severity of EAE [76], further 
supporting a role of astrocytes in limiting EAE lesions. As mentioned before, astrocytes, 
which are intimately associated with blood vessels [67] and constitute the glia limitans 
apposed to the BBB, regulate leukocyte trafficking into the CNS. At the BBB, astrocytic 
endfeet release, upon activation, inflammatory cytokines, including IL-6, TNF-alfa and 
IL-1beta: these factors can inhibit tight junctions in adjacent endothelial cells [77], thus 
increasing BBB permeability and favour  influx of immune cells into the brain. On the 
other hand, reactive astrocytes can also promote tight junctions formation in endothelial 
cells and BBB integrity via Sonic hedgehog pathway, to counteract brain inflammation 
[78]. 
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Figure  7:  Increased spread of infiltrating inflammatory cells during EAE with ablation of 
proliferating reactive astrocytes.  A1–A3, B1–B3, Single-channel and merged  two-color fluorescence 
survey images of spinal cord sections stained for GFAP (green) and the nuclear counterstain, DAPI 
(blue), in GFAP-TK transgenic mice that were induced with EAE and given either PBS (EAE + TK/PBS) 
as a vehicle control (A1–A3), or GCV (EAE + TK/GCV) to ablate transgene expressing astrocytes (B1–
B3). Note that in EAE + TK/PBS, DAPI-stained infiltrating inflammatory cells (A1) are found primarily in 
dense perivascular clusters (e.g., 1–3) surrounded by intensely stained GFAP-positive astrocytes (A2, 
A3). In EAE + TK/GCV (B1–B3), inflammation is markedly increased and there is little perivascular 
clustering in comparison with EAE + TK/PBS; instead, DAPI-stained infiltrating inflammatory cells (B1) 
spread widely in the parenchyma of the white matter. GFAP staining shows that the white matter is 
substantially depleted of GFAP-positive astrocytes in EAE + TK/GCV (B2), and double staining reveals 
that the spread of DAPI-positive inflammatory cells is heaviest in areas depleted of astrocytes (B3). Scale 
bar, 50 μm.[75]  
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2.1.3 Astrocytes exhibit calcium-mediated intercellular communication 
 
Astrocytes display very stable membrane potential and unlike neurons are not capable 
of generating action potentials [79]. Thus, astrocytes have classically been regarded as 
electrically silent, nonexcitable, cells. However, astrocytes display their excitability 
through variations in intracellular calcium [Ca2+]i [80-82]. Astroglial cells display 
spontaneous [Ca2+]i oscillations in vitro [83, 84] and it has been shown that even in situ 
astrocytes from brain slices show spontaneous [Ca2+]i oscillations [85, 86]. Many 
neurotransmitters stimulate [Ca2+]i elevations in astrocytes by activating corresponding 
receptors expressed on their surface. By the use of fluorescent Ca2+ indicators, it has 
been demonstrated that intracellular Ca2+ oscillations could be both spontaneous as 
well as evoked by neuronal activity. Spontaneous Ca2+ signals are mostly restricted to 
single astrocytes and occur independently of the activity of neighboring cells [87], while 
activity-mediated Ca2+ oscillations occur in groups of different astrocytes that respond 
to the same neuron-derived stimulus [88]. Both spontaneous and neuronal activity-
evoked Ca2+ oscillations trigger the release of active transmitters from astrocytes, in a 
process named ―gliotransmission‖. Gliotransmitters  comprise glutamate [56, 89], D-
serine [90], tumor necrosis factor alfa (TNFa) [91] and ATP [92, 93] and many other 
active compounds. Remarkably [Ca2+]i oscillations can spread from one astrocyte to 
adjacent cells to form synchronous Ca2+ oscillations or Ca2+ waves. Different studies 
proved that calcium wave propagation among astrocytes is dependent on both an 
intercellular gap-junction pathway, involving calcium and inositol 1,4,5-trisphosphate 
(IP3) [84, 94-96], and an extracellular pathway, involving release of ATP and/or 
glutamate and activation of metabotropic receptors on neighbouring cells [97]. In the 
presence of the gap-junction blocker anandamide (100 μM), ATP release was found to 
represent the main factor controlling propagation of calcium wave in hippocampal 
cultures [93]. Consistently, subsequent findings revealed that both spontaneous and 
evoked Ca2+ propagation can be reduced or even abolished by purinergic antagonists 
or the ATP-degrading enzyme apyrase (figure 8A) [92, 97-99] indicating that 
extracellular ATP and activation of P2 receptors are largely responsible for spontaneous 
and evoked Ca2+ events. These findings identify extracellular ATP as the primary 
molecule involved in calcium-mediated cross-talk among astrocytes and between 
astrocytes and other cell types in the central nervous system.  
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Figure 8: Neuronal activity-independent Ca2+ transients in astrocytes. (A) (a) Neuronal Ca2+ 
oscillations seen in the hippocampal neurons (blue traces shown as 3 and 4) are highly synchronous and 
are inhibited by tetrodotoxin (TTX) . Adjacent astrocytes (red traces shown as 1 and 2) also show slower 
and less synchronous Ca2+ oscillations. However, the synchronous Ca2+ oscillations in astrocytes are 
unaffected even when neuronal activities are inhibited by TTX, suggesting that astrocytes have 
mechanism(s) by which they form neuronal activity-independent Ca2+ transients. (b) Astrocytes reveal 
synchronous Ca2+ transients (red traces 5 and 6) when neurons are not present (purified astrocytes). 
Astrocytic Ca2+ oscillations seen in the presence of TTX or in purified astrocytes were abolished by the 
ATP-degrading enzyme apyrase. (B) Schematic cartoon of neuronal activity-independent astrocytic Ca2+ 
oscillations. One or some initiator astrocyte(s) release ATP, and this is followed by ATP-dependent Ca2+ 
transients that propagate into adjacent astrocytes.[98] 
 
 
The source of astrocyte Ca2+ elevations appears to be almost exclusively inositol1,4,5-
triphosphate receptor (IP3R) sensitive intracellular store, activated following G-protein 
coupled receptors GPCRs stimulation and  involving the canonical phospholipase C 
(PLC) /IP3 pathway. Upon Gq GPCR activation, PLC hydrolyzes the membrane lipid 
phosphatidylinositol 4,5-bisphosphate (PIP2) to generate diacylglycerol (DAG) and IP3, 
leading to IP3R activation and Ca2+ release from the endoplasmic reticulum (ER) 
(figure 9). In fact, incubation of astrocytes with thapsigargin (2 μmol/L), an irreversible 
inhibitor of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase, to deplete ER  Ca2+ 
stores, completely prevents spontaneous Ca2+ oscillations [86, 100]. Moreover, 
spontaneous and evoked astrocyte Ca2+ elevations are  almost completely abolished 
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by removal of the astrocyte-specific IP3R type2 (IP3R2) receptors [101-103]. Taken 
together the above evidences indicate that both evoked and spontaneous Ca2+ 
elevations are driven almost exclusively by Gq GPCR-coupled release from intracellular 
stores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  9: Diagram of the major fluxes involved in the control of calcium oscillations in non-
excitable cells.  Abbreviations: R (agonist receptor), G (G-protein), PLC (phospholipase C), SOC (store-
operated channels), AAOC (arachadonic acid-operated channels), RyR (ryanodine receptor), Icrac 
(calcium release-activated channel). 
 
 
2.1.4 Gliotransmission. Focus on ATP 
Gliotransmission has been an exciting area of neuroscience research since its initial 
discovery in 1994 [56]. Gliotransmitters include a large number of neuroactive 
molecules, such as (a) excitatory, inhibitory and modulatory aminoacids (D-serine, 
glutamate, aspartate, GABA, glycine, homocysteine and taurine) [104, 105], (b) ATP 
and related nucleotides and nucleosides (purine, nucleotides), (c) eicosanoids and other 
lipid mediators (prostaglandins) [106] (d) neuropeptides (proenkephalin, 
angiotensinogen, endothelins, atrial natriuretic peptide (ANP), neuropeptide Y (NPY), 
(e) neurotrophins (nerve growth factor (NGF), neurotrophin-3, brain-derived 
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neurotrophic factor (BDNF) [107], (f) cytokines (interleukins, interferons, TNF-α) [91], (g) 
structurally associated chemokines and (h) growth factors. As I mentioned in the 
previous paragraph, a link between gliotransmission and Ca2+ evoked regulated 
secretion has been described only for some of the molecules released by astrocytes: in 
fact, while Ca2+ dependent release has been proven for glutamate [56, 89], ATP [92, 
93] and D-serine [90], for many other active agents the Ca2+-dependency of their 
secretion has not been proven or tested yet. Moreover, alternative routes of release, 
independent from Ca2+ mobilization [108, 109] also exist for gliotransmitters, such as 
glutamate and ATP, which are secreted through vesicular mechanims [110]. For 
example ATP can be released from astrocytes by (1) Ca2+-dependent exocytosis [111-
113] (2) by a regulated form of exocytosis ,(3) through hemichannels formed by 
connexins and pannexins, and finally (4) through plasmalemmal voltage-dependent 
anion channels and purinergic receptor (P2XRs) (figure 10).[109, 114]  
Two different types of secretory vescicles mediate regulated ATP exocytosis: large 
dense core vesicles, which store secretogranin II (Sg II) [115-117], peptides (ANP) and 
a fraction of cellular ATP [93] [60, 118] and secretory lysosomes [119-121] which 
contain ATP but not glutamate. Secretory lysosomes have been recently suggested to 
represent  the major vesicular compartment undergoing calcium regulated exocytosis in 
astrocytes [119-122]. To fuse with the plasma membrane, secretory lysosomes use  the 
vesicular SNARE protein TI-VAMP, also called VAMP7, which is typical markers for 
these secretory organelles (figure 11 )[123, 124]. 
 
 
 
 
 
 
 
 
 
 
Figure 10:  Multiple pathways for the release of ATP.  Hemichannels of connexin or pannexin, maxi-
anion channels, P2X7 receptors and Cl channels are pathways through which ATP can flow. In addition, 
the existence of exocytotic ATP is also suggested. 
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The existence of vesicular mechanisms of ATP secretion in vivo was supported by 
studies of Philip Haydon‘s laboratory, which were performed [60] in transgenic mice 
expressing, selectively in astrocytes, a dominant-negative SNARE domain, that blocks 
regulated exocytosis, Indeed, the authors found that secretion of ATP and its 
subsequent conversion to adenosine is strongly inhibited in the brain of these 
transgenic mice [60] [125]. Very recently it has been also identified the vesicular 
nucleotide transporter which mediates ATP  storage within  astrocytic vesicles: 
SLC17A9, a novel member of the anion transporter family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: TI-VAMP silencing reduces the amplitude and the speed of calcium wave propagation. 
(A and B) Pseudo-colour images of the changes in the calcium concentration (F340/380 signal) in control 
(A) and TI-VAMP silenced (B) astrocytes taken 0.5, 2, 4, and 7 s after mechanical stimulation in the 
presence of 100 μM anandamide. (C) Pseudocolour images of calcium wave propagation at 0.5 and 7 s 
in astrocytes pre-incubated with the ATP degrading enzyme apyrase (30 μ/mL) and the purinergic 
receptor antagonist oATP (300 μM).[122] 
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2.2.1 Role of extracellular adenosine-5’-triphosphate (ATP) in the adaptive 
immune response 
 
In healthy tissues, ATP is almost exclusively localized intracellularly (in the 5-10 mM 
range), whereas its extracellular concentration is very low (in the 10–100 nM range). 
After injury or in response to stimulation, cells may undergo formation of transient 
breaches in the plasma membrane from which ATP may easily efflux, driven by the 
large chemical gradients (106-fold gradient for ATP efflux; millimolar versus nanomolar). 
Extracellular ATP (eATP) concentration is maintained low by the activities of 
extracellular ecto-apyrases and ectoadenosine triphosphatases (ecto-ATPases), which 
metabolize ATP into adenosine 5'- diphosphate (ADP), adenosine 5'-monophosphate 
(AMP), and adenosine. Thanks to the function of these enzymes, leakage of a very 
small fraction of intracellular ATP is sufficient to elevate extracellular levels at 
concentrations active on purinoreceptors (P2Rs). Therefore ATP is generally 
considered an ubiquitous ‗danger signal‘ or DAMP (Damage Associated Molecular 
Pattern), especially in the immune system. Extracellular ATP concentration can also 
increase in the absence of cell damage, as virtually all cells, possess secretory 
pathways for non-lytic ATP secretion (i.e. ABC transporters, non-selective large 
conductance channels such as connexins and pannexins, constitutive or stimulated 
exocytosis). [126, 127]. Among the purinoreceptors, P1Rs (now known as A1, A2, and 
A3 receptors) respond to adenosine but not to ATP, whereas all P2Rs respond to ATP, 
with some also responding to adenosine diphosphate (ADP), uridine 5'-triphosphate 
(UTP), or uridine 5'-diphosphate (UDP). Two main classes of purinergic P2 receptors 
have been identified: P2X receptors (P2X1- P2X7), which are Ca2+-permeable, 
nonselective ligand-gated ion channels, and G protein protein–coupled receptors 
(P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 to P2Y14 receptors), which bind also ADP, 
UDP, UTP, or uridine diphosphate glucose (UDP-glucose). Activation of P2 receptors 
regulates a myriad of cellular functions ranging from survival and proliferation to 
apoptosis. Therefore the final effect of extracellular ATP on a given cell depends on the 
composition of P2 receptors expressed on its surface .P2X1, P2X4, and P2X7 and  
several functional P2Yrs are found on T cells [128] as are. Most P2Rs are sensitive to 
micromolar concentrations of eATP.  The P2X7 receptor is an unusual non-selective 
cation channel, whose activation requires higher ATP concentrations (>100 μM) 
compared to the other members of the P2X receptor family. ATP binding to P2X7 
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receptor induces a depolarizing ionic current within milliseconds. Persistent activation of 
the receptor leads to the formation of a pore permeable to larger molecules such as 
ethidium bromide. For a long time the molecular composition of the P2X7 pore has been 
a matter of a great discussion. However, it has been recently described that P2X7 
receptor interacts with the pannexin-1 hemichannels which may constitute the path for 
uptake of large molecules [129].  
 
2.2.2 Extracellular ATP shapes CD4+T cell functional responses 
The importance of extracellular ATP for cell-to-cell communication in the nervous and 
vascular systems has been thoroughly studied for years, but its role in the immune 
system is less known. Several studies have shown that ATP regulates T-cell activation 
and function [42, 130]. However a coherent picture of responses evoked by ATP in  T 
cells is not currently, available, because of the contrasting results obtained in different 
studies [131-133]. Two recent studies demonstrated that eATP is important for cell-to-
cell communication in the immune system. In the first study, Grassi and collaborators 
showed that T cell activation induces ATP synthesis and release, thus activating 
purinergic receptors on T cells in an autocrine fashion [42]. Moreover, they 
demonstrated that the activation of P2X7 by ATP inhibits the suppressive potential and 
stability of T regulatory cells (Treg). In fact, increased ATP synthesis, induces the in vivo 
conversion of T regs to IL-17–secreting T helper 17 (Th17) effector cells [134]. In 
another study, the team of Takeda proposed that ATP released by commensal bacteria 
drives the differentiation of intestinal T helper 17 (TH17) cells [135]. More in details, 
Takeda and colleagues showed that i) commensal bacteria release large amounts of 
ATP, although not enough to deliver a ―danger‖ inflammatory signal to the intestinal 
mucosa ii) the number of Th17 cells increases in bacteria-free mice upon treatmentg 
with adenosine 5'-O-(3-thiotriphosphate), a nonhydrolyzable form of ATP, while 
decreases upon treatment with apyrase, which degrades ATP. Finally the percentage of 
Th17 cells measured in a co-culture of T cells and DCs is strongly increased by the 
addition of the bacterial supernatant, and this effect is apyrase sensitive. 
All these findings highlight a major  role of  ATP in the intercellular communication in the 
immune system.   
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3.1.1 Modulators of extracellular ATP levels: The ectonucleotidases CD39 and 
CD73. 
 
The pool of extracellular nucleotide (NTPs) is controlled by ectonucleotidases (E-
NTPDases), which remove NTPs by degrading them to NMP (nucleoside 
monophosphate) [136, 137]. Members of this enzyme family are expressed on the 
surface of various cells, including astrocytes, microglia and T cells in the brain. Of this 
family, E-NTPDase1 (also called CD39) is the dominant ectoenzyme in the immune 
system [138]. As shown in figure 12, CD39 dephosphorylates ATP to AMP, removing 
one phosphate at a time with a modest appearance of ADP [139]. 
Monophosphonucleosides (for example, AMP) are further hydrolysed to nucleosides 
(adenosine) by ecto-5‘-nucleotidase (CD73), a glycosyl phosphatidylinositol-anchored 
enzyme located at the cell surface [140]. In addition to CD39 and CD73, which are the 
major nucleotide metabolizing enzymes that regulate immunity and inflammation, there 
are other less well characterized cell surface-associated enzymes, involved in the 
catabolism of extracellular nucleotides, which include alkaline phosphatases, 
pyrophosphatases, and phosphodiesterases, as well as the counteracting ATP-
regenerating ectoenzymes adenylate kinase and nucleoside- diphosphate kinase [141].   
Although the impact of extracellular ATP on the immune system is well established 
[142], the importance of CD39 in immune regulation is not yet clear. Besides removing a 
proinflammatory stimulus, CD39 may also act in concert with CD73, to produce 
adenosine. This nucleoside exhibits mostly inhibitory and antiproliferative effects [142].  
Hence, the overall effect of CD39 activity should be mainly immune suppressive. 
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Figure 12: CD39/CD73 in inflammatory event. The occurrence of pathological events, such as 
inflammation, promotes a massive accumulation of ATP, which serves as a key ‗danger‘ signal, triggering 
a series of proinflammatory responses (A). However, negative feedback also takes part in this context 
because increased ATP secretion, as observed in the early phase of inflammation, is followed by its 
sequential degradation to AMP by CD39, and to adenosine by CD73. Adenosine promotes a depressive 
action on the immune cell activity and exerts a potent anti-inflammatory effect.[143] 
 
 
3.1.2 T regulatory cells express CD39/CD73 ectonucleotidases  
Several regulatory mechanisms are used to maintain immune homeostasis, preventing 
autoimmunity and moderating the inflammation induced by pathogens and 
environmental insults. In this regard, Tregs are widely considered the primary mediators 
of peripheral tolerance, playing a pivotal role in preventing autoimmune diseases, as 
well as in limiting chronic inflammatory disorders. There are a number of mechanisms 
by which Tregs suppress proliferation and cytokine production by other cells, including 
depletion of IL-2, direct toxicity through granzyme or perforin, or via cytokines, such as 
IL-10, TGFb, or IL-35 [144]. A specific feature of Foxp3+ Tregs is the surface 
expression of CD39 and CD73, which are increasingly used as markers of this 
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lymphocyte population [145, 146]. The catabolic activity of the CD39/CD73 axis is 
synchronized with the activation status of the cells. Indeed, murine Tregs display 
increased CD39 activity only upon activation of their T cell receptor (TCR), while the 
enzyme is inactive in non-stimulated cells [147]. The increase in the  ATP metabolizing 
activity appears to be critical for the immunosuppressive activity of Tregs [148]. It was 
speculated that the enhanced CD39 activity allows the entrance of  Tregs into inflamed 
regions, where it reduces the extracellular ATP levels, thereby decreasing P2 receptor-
mediated Treg cell death [148]. Deaglio et al. [149], using CD39-deficient mice, showed 
that CD39, in concert with CD73, facilitates the pericellular generation of adenosine, 
which mediates many of the immune suppressive and anti-inflammatory activities of 
Tregs. 
 
 
 
 
3.1.3 Th17 Cell immunosuppressive activity via ectonucleotidase expression 
Th17 cells are a subtype of CD4+ T lymphocytes, characterized by high expression of 
IL-17A (also called IL-17), a proinflammatory cytokine involved in the pathogenesis of 
various autoimmune diseases [12, 150]. Th17 cells are important for host defense 
against extracellular microorganisms and are involved in the pathogenesis of diverse 
immune-mediated diseases, including multiple sclerosis [151]. In addition to IL-17A, 
Th17 cells are characterized by secretion of IL-17F, IL-21, and IL-22, and expression of 
the IL-23 receptor (IL-23R) [152]. IL-17A, IL-17F, IL-22, and IL-21 contribute to 
inflammation through several mechanisms [153], by inducing the recruitment and 
expansion of myeloid cells including neutrophils and macrophages [154]. Th17 are also 
characterized by the expression of the transcription factor retinoid orphan nuclear 
receptor (encoded by RORC), which specifies the Th17 cell lineage [155]. 
Characterization of the phenotypic and functional properties of Th17 cells has been 
carried out in vitro after differentiation from naı¨ve CD4+ T lymphocytes. In mice, Th17 
cells are commonly obtained by culturing naı¨ve CD4+ T cells isolated from spleen and 
lymph nodes in the presence of antibodies to CD3 and CD28 as well as the polarizing 
cytokines transforming growth factor-b (TGF-b) and IL-6 [156, 157]. IL-23, an IL-12 
 24 
 
family member, does not initiate Th17 differentiation alone but favors Th17 proliferation 
and maintains the Th17 cell transcriptional program. However, it was recently shown 
that TGF-b is dispensable for the induction of Th17 cells. Indeed, Th17 cells can be 
obtained from naı¨ve CD4+ precursors upon culturing with IL-1b, IL-6, and IL-23 without 
TGF-b [158]. In addition to their capacity to produce IL-17A and express the 
transcription factor RORgt, Th17 cells produce IFN-ϒ and express T-bet (Th1 lineage). 
Taken together, these data suggest that Th17 polarization of murine naı¨ve CD4+ T 
cells during T cell receptor (TCR)-mediated activation in vitro can be obtained through 
at least two pathways, one requiring TGF-b with IL-6, and the other involving the 
proinflammatory cytokine IL-1b with IL-6 and IL-23 without TGF-b. Studies regarding the 
role of Th17 cells in cancer and tumor progression, showed that despite the ability of 
Th17 cells to promote tissue inflammation and autoimmunity, Th17 cells can also act as 
immunosuppressor cells with the capacity to suppress the immune response against 
tumors and consequently enhance cancer growth. At least two separate mechanisms 
have been identified that may sustain Th17 immunosuppressive effect: (i) Th17 cells 
can progressively convert to Tregs because of their plasticity, and (ii) they can produce 
immunosuppressive adenosine upon TGFb-dependent ectonucleotidase expression. 
Th17 cells differentiated with TGF-b and IL-6, but not those induced with IL-1b, IL-6, 
and IL-23, express CD39 and CD73 ectonucleotidases on their surface [159]. The 
ectonucleotidase expression actually determines the effectors immunoregulatory 
function of Th17 cells. The concomitant expression of these two enzymes transforms 
ATP or ADP liberated by damaged cells in the tumor microenvironment into adenosine 
which play a major role in immunosuppression [149]. Ectonucleotidase expression on 
Th17 cells is determined by TGFb and IL-6 signaling through the transcription factors 
Gfi1 (growth factor independent protein 1) and Stat3 (signal transducer and activator of 
transcription 3): TGF-b downregulates Gfi1, a repressor of ectonucleotidase expression, 
whereas IL-6 activates Stat3, a promoter of ectonucleotidase expression (figure 13). 
The combined effect results in the transactivation of the CD39 and CD73 promoters 
[159]. These results suggest that ectonucleotidase expression actually determines the 
effector immunoregulatory function of Th17 cells.  
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13:  Contrasting effects of T helper 17 (Th17) cells on cancer progression. Mouse Th17 cells 
secreting interleukin (IL)-17A and expressing the Th17 transcription factors signal transducer and 
activator of transcription 3 (Stat3) and RORgt (retinoid orphan nuclear receptor gt) can be induced from 
naı¨ve CD4 T cells using IL-1b, IL-6, and IL-23 (a) or transforming growth factor-b (TGF-b) and IL-6 (b). 
(a) Th17 cells differentiated without TGF-b express the Th1 cell transcription factor Tbx21 and secrete 
interferon-g (IFNg) but not the immunosuppressive cytokine IL-10. They also express the transcription 
factor growth factor independent protein 1 (Gfi1) . Upon adoptive transfer, these cells promote activation 
of CD8 effector T cells and tumor regression in an IL-17- and IFN-g-dependent manner. (b) Th17 cells 
generated in the presence of TGF-b fail to produce IFN-g but secrete IL-10. They also feature reduced 
expression of Gfi1, resulting in the expression of the CD39 and CD73 ectonucleotidases, which can 
convert ATP to adenosine, thereby contributing to the inhibition of anticancer immunity.[160] 
 
 
4. Multiple sclerosis and EAE. The possible scenario of astrocyte- T cell 
interaction 
Multiple sclerosis is a chronic, progressive inflammatory disorder which principally 
affects the brain and spinal cord. Pathological hallmarks of MS are the inflammatory 
plaques and the presence of inflammatory cells and their products in the brain lesions. 
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CD4 T cells, autoreactive against myelin, play a major role in the pathogenesis of MS. 
They pass into the parenchyma in response to chemotactic signals through the BBB 
[161]. Once entered the CNS, T cells are re-activated by microglia, which bear MHC 
class II and secrete pro-inflammatory cytokines (figure 14) [162]. Autoreactive T cells 
mediate damage against neurons, their axons and myelin sheaths. Indeed the key 
morphological feature of MS is demyelination of nerve axons, which leads to block of 
signal conduction or conduction slowing at the site of demyelination. The most common 
form of MS, termed relapsing– remitting MS (RRMS), is associated with acute 
inflammatory episodes resulting in neurological deficits. Patients may experience some 
recovery between relapses, but 80% of patients with RRMS evolve to a more 
progressive form, termed secondary progressive MS (SPMS). This form is associated 
with a gradual loss of neurological function and ascending paralysis and is thought to be 
independent of inflammation. The best characterized and studied animal model of MS is 
the experimental autoimmune encephalomyelitis (EAE). EAE is induced in susceptible 
animals by immunization with myelin antigens, emulsified in complete Freund‘s adjuvant 
(CFA) [163] or  by adoptive transfer of activated myelin-specific CD4+ T cells from mice 
with EAE into naive recipient mice (figure 14) [164]. The EAE model has provided a 
useful tool for studying the inflammatory processes throughout the disease course. 
However, there are significant differences between MS and EAE as indicated by the fact 
that certain therapies had opposite outcomes in the murine and human patologies. EAE 
is a multi-step inflammatory process initiated by Th1 and Th17 cells. During actively 
induced EAE, myelin-specific Th1 or Th17 cells are activated and expand in the 
peripheral lymphoid tissues in response to myelin peptide and complete Freund‘s 
adjuvant (CFA) immunization. Activated Th1 or Th17  cells cross the blood brain barrier 
(BBB) thanks to the interaction of very late activation antigen 4 (VLA-4) expressed on 
their surface with vascular cell adhesion molecule (VCAM) expressed on endothelial 
cells [32]. Figure 15 shows that infiltrating T cells are then re-activated by brain-resident 
antigen presenting cells (including microglia, macrophages and myeloid dendritic cells) 
[165]. Interaction with APCs triggers the release of inflammatory cytokines from Th1 or 
Th17 cells thereby causing local inflammation and demyelination of white matter tracts, 
which reduces the ability of axons to conduct electrical signals. Astrocytes are involved 
in nearly all processes within the brain, but their contribution to EAE pathogenesis is not 
certain. In vitro studies suggest that they also produce cytokines that modulate T cells 
function as well as chemokines that may attract additional peripheral inflammatory 
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leukocytes. A number of studies have highlighted the central role of Th17 cells in the 
development and pathogenesis of EAE. Firstly, mice lacking RORgt, IL-17 or IL-23 as 
well as mice treated with IL-17-blocking antibodies are less susceptible to EAE than 
wild-type or untreated mice. Secondly, EAE can be induced by transfer of either Th-17 
or Th-1 cells [166, 167] and the Th-17/Th-1 ratio of infiltrating cells determines where 
inflammation occurs in the CNS [168]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  14:  EAE can be instigated in one of two ways. Active induction involves injecting animals with 
antigens such as brain or spinal cord tissue or myelin proteins such as MOG, PLP, or MBP—along with 
Mycobacterium tuberculosis and often pertussis toxin, both of which act as immunostimulants. For 
adoptive transfer, researchers first immunize an animal with these antigens and immunostimulants, and 
after a week or two remove its lymph nodes, extract antigen-primed lymphocytes, and grow them in 
culture. These activated immune cells are then injected into another animal to induce the disease. 
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Figure 15: Migration and effector function of T cells in the central nervous system (CNS) during 
experimental autoimmune encephalomyelitis (EAE). After immunization with myelin antigens, 
complete Freund‘s adjuvant (CFA) and pertussis toxin, dendritic cells (DCs) are activated in the lymph 
nodes by Toll-like receptor (TLR) agonists within the mycobacterium tuberculosis component of CFA, and 
present myelin antigen to naive T cells. The activated myelin-specific T cells enter the bloodstream and 
traffic to and enter the CNS. Breakdown of the blood–brain barrier (BBB) occurs, allowing recruitment of 
other inflammatory cells into the CNS. T cells entering the CNS encounter their cognate myelin antigens 
and become reactivated by local APC. T cells expand and release inflammatory mediators which help 
recruit other immune cells to the site of inflammation. Activation of local microglial cells and infiltrating 
cells results in production of proteases, glutamate, reactive oxygen species and other cytotoxic agents 
which promote myelin breakdown. Damage to the myelin sheath surrounding axons is followed by axonal 
damage and neurological impairment. [16] 
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MATERIALS AND METHODS 
 
Mice 
The animal use procedures, performed according to the EC Directive 86/609/EEC, were 
approved by the Institutional Animal Care and Use Committee of the Humanitas 
Research Institute. Animals were sacrificed after gentle carbonarcosis (by slowly rising 
CO2 inside the cage) to minimize pain and discomfort. 
 
Primary cell cultures 
Astrocytes cultures: cortical and hippocampal astrocytes were obtained from 2 day-old 
C57BL/6 mice. Cortex and hippocampus were freshly dissected, cut into small sections 
and washed in Hank's Balanced Salt Solution supplemented with Hepes /Na pH 7.4 (10 
mM), MgSO4 (12 mM), 50 U/ml Penicillin and 50 μg/ml Streptomycin. The tissue was 
then dissociated with 2.5 mg/ml trypsin type IX in presence of 1 mg/ml 
deoxyribonuclease (DNase, Calbiochem) for 10 min at 37 °C in two subsequent steps 
and the supernatants obtained were diluted 1:1 in medium containing 10% fetal bovine 
serum (FBS). The cells were plated in MEM (Life Technologies) supplemented with 
10% FBS, 33 mM glucose, 100 mM Na2+/ Pyruvate (Lonza), 50 U/ml penicillin-G and 
50 ug/ml streptomycin and maintained in 75 cm2 flasks (1 for pup) at 37 °C in a 
humidified 5% CO2 incubator. Pure cultures (> 99.5%) of astrocytes were obtained by 
shaking flasks at 220 rpm for 24 h at 37 °C at day 2 and 6 after plating. Shaking 
medium (5 ml/flask) was Minimum Essential Medium with Hank's salts, supplemented 
with 10% horse serum, 33 mM glucose, 200 mM Ultraglutamine (Lonza), 10 mM Hepes/ 
Na pH 7.4, 50 U/ml Penicillin and 50 μg/ml Streptomycin.  
T-cell cultures: CD4+ T cells were isolated from peripheral lymph nodes and spleens of 
C57BL/6 female mice by positive selection with anti-CD4 immunomagnetic beads 
(MiltenyiBiotech). CD4+ T cells were stimulated with plate-bound anti-CD3 (10 ng/ml) 
and anti-CD28 (5 ng/ml) (Biolegend)  mAbs for 40 h in RPMI-1640 medium 
supplemented with 5% FBS, 100 U/ml penicillin and 100 g/ml streptomycin. 
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Microglia and peritoneal macrophages cultures: Primary microglia cells were obtained 
from astrocytic layers by shaking the flasks for 45‘ at 230 rpm, 10–12 days after 
dissection. Detached cells (about 90% microglia with a 10% astrocytic contamination) 
were plated in multiwells (150,000 cells per well in 12 well plates) coated with poly-L-
ornithyne hydrobromyde (100 μg/ml). Cultures usually contained 95% microglial 
(CD11b+) cells. To obtain peritoneal macrophages culture, mice were killed by 
asphyxiation with CO2 cellular material was aspirated from peritoneum and spun at 400 
× g at 4 °C for 10 min. Cell culture were seeded in RPMI with 10 % FCS at 1x106 
cells/well in 12-well plates cultured at 37 °C in an atmosphere of 5 % CO2. After 1 h 
non-adherent cells were removed by washing three times with PBS. After 24h adherent 
macrophages/ microglial cells were co-cultured with CD4+ T cells at macrophage/ 
microglia: T cell ratio 1: 2. 
 
Astrocyte/ T-cell co-cultures 
Astrocytes were dissociated using trypsin-EDTA (Life Technologies-BRL), collected by 
centrifuging at 800 g for 10 min and then re-plated on multiwells (12 well plates; 
300.000 cells/well) coated with poly-L-lysine (0,02 mg/ml). The same day of astrocytes 
plating, CD4+ isolated T cells were activated with CD3/CD28 mAbs for 40 h and then 
plated in 24-well plates alone or in 12 well plates in co-culture with astrocyte. 
Astrocyte:T-cell ratio was 1:2 and the co-culture was maintained in RPMI-1640 medium 
supplemented with 5% FBS, 100 U/ml penicillin and 100 g/ml streptomycin in the 
presence of 90 U/ml IL-2. In order to prevent cell-cell contact between astrocytes and T-
cells, a transwell system was used  (0.3 uM membrane pore; Transwell System, 
Corning).  
 
Antibodies and Immunofluorescence analysis 
The following antibodies were used: mouse anti-GFAP (1:500; Sigma), rabbit anti-GFAP 
(1:400; Synaptic System), rabbit anti-IBA1 (1:200; Wako), (PE)-conjugated rat anti-
MHCII (1:100; eBioscience), FITC-conjugated Armenian Hamster anti-CD80 (1:100, 
eBioscience), PE-conjugated rat anti-CD86 (1:100, Biolegend), rabbit anti-CD3 (1:150, 
Dako), mouse anti-CD4 (1:300; Abcam), APC-conjugated rat anti-CD73 (1:150, 
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Biolegend), Pe-Cy7-conjugated rat anti-CD39 (1:200, eBioscience). Secondary 
antibodies used were conjugated with the following fluorophores: Alexa-488, Alexa-555 
or Alexa-633 (Invitrogen, San Diego, CA).   
Immunofluorescence analysis: cell cultures plated on poly-lysine pre-coated glasses 
were fixed in a solution containing 4% formaldehyde and 4% sucrose for 20‘ at room 
temperature, and the washed with PBS 1X. Briefly, cells were washed three times in a 
buffer solution containing low salt concentration (150 mM NaCl, 10 mM Phosphate 
Buffer 240 mM pH 7.4) followed by three washes with buffer solution containing high 
salt concentration (500 mM NaCl, 20 mM Phosphate Buffer 240 mM pH 7.4), and then 
permeabilized with GSDB 1X (15% Goat serum, 0.3% tryton, 450 mM NaCl, 20 mM 
Phosphate Buffer 240 mM pH 7.4) for 30 min at room temperature. The primary 
antibodies were diluted in GSDB 1X and incubated for 2 hours at room temperature. 
After three washes of 10 min with high salt solution, the secondary antibodies (diluted in 
GSDB 1X) were incubated for 1 hour at room temperature in the dark. Cells were then 
washed three times with high salt solution followed by three washes with low salt 
solution 5 min each, and incubated with DAPI solution. Coverslips were mounted onto 
glass using the mounting medium for fluorescence Vectashield (Vector Laboratories). 
Images were acquired using a Leica SPE confocal microscope equipped with an ACS 
APO 63X/1.30 Oil objective. Images were processed by using Photoshop (Adobe) and 
ImageJ Software. 
 
Bioluminescence Assay to Measure ATP 
ATP levels in the extracellular saline (KRH) of astrocyte monolayers alone, CD4+ T cell 
WT or NTPDase1-/-  and astrocyte- T cell co-culture, in the presence of the ecto-ATPase 
inhibitor ARL (100 μM, Sigma), were measured using a luciferin/luciferase-based ATP 
determination kit (Molecular Probes, Leiden, NL) according to the manufacturer‘s 
instructions and a luminometer (Infinte F500, Tecan). Each sample was run in triplicate. 
Samples were assayed within 5 min of collection. 
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Calcium imaging 
Astrocytes cultures used for calcium imaging experiments were plated onto glass 
coverlips of 25 mm diameter pre-coated with poli-L-lysine (0.02 mg/ml). Cells were 
loaded with Oregon Green-488 (Molecular Probes) for 1 h at 37°C, 5% CO2 in RPMI 
5% FBS. Coverslips were mounted on a recording chamber (Warner Instruments, 
Hamden, CT) and placed on the stage of an IX-71 inverted microscope (Olympus, 
Hamburg, Germany) equipped with an EMCCD (electron-multiplying CCD) camera 
(quantem 512x512, photometrics). Illumination was obtained using a light-emitting diode 
LED (Cairn research, Optoled Lite), with an oil-immersion 40X objective (1.3 NA). 
Regions of interest (ROIs) of about 15-pixel area were drawn on the cell cytoplasm of 
virtually all the cells in the recorded field. The time lapse recording of spontaneous 
calcium dynamics was performed with an acquisition rate of 5 Hz for 200 seconds and 
off-line analyzed with MetaFluor software (Molecular Devices). Cultures were imaged in 
KRH (Krebs-Ringer-Hepes) extracellular solution containing (mM) 2 CaCl2, 125 NaCl, 
1,2 MgSO4, 25 HEPES, 5 KCl, 6 glucose, 1,2  KH2PO4, pH 7.3. 
 
Calcein exchange experiments 
Astrocytes were incubated for 30 min at 37°C with 1 µM of the gap junction-permeant 
green fluorescent dye Calcein Acetoxymethyl ester (AM; Molecular Probes). As 
negative control we used 1 µM of gap junction-impermeant CellTracker CMFDA (Alexa 
Fluor 488) (5-Chloromethylfluorescein Diacetate). After three washes with PBS solution 
containing 2% FBS, astrocytes were co-cultured with activated T cells. Calcein transfer 
from dye-loaded astrocytes to CD4 T cells was evaluated by flow cytometry 
(FACSfortessa, Becton Dickinson, UK) and the percentage of green Calcein-positive 
CD4+ T cells were quantified. 
 
Flow cytometric analysis 
Floating CD4+ T cells were collected by three wash in PBS 2% FBS, while adherent T 
cells were detached from astrocyte monolayer by Accutase (Millipore). Then they were 
surface stained with the following conjugated antibody: FITC-conjugated anti-CD4 
(Biolegend), V450-conjugated  anti-CD45.2 (BD), PE-conjugated anti-Cd11b 
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(Biolegend), Pecy7- conjugated anti-CD39 (eBioscience), APC-conjugated anti-CD73 
(Biolegend), FITC- conjugated anti-CD49d (integrin a4 chain, BD) and PE-conjugated 
anti-CD29 (integrin b1 chain, BD). The analysis was performed by using FlowJo 
Software. 
 
Intracellular Cytokine Secretion Analysis 
Cytokine producing T cells were detected by intracellular staining after three hours of 
incubation with PMA (100 nM) and ionomycin (1 uM). Brefeldin A (10 ug/ml) was added 
for the last 3 hours of incubation together with PMA and ionomycin thus preventing 
cytokine release into the medium. After cell surface staining, T cells were fixed and 
stained with the following mAbs: PE-conjugated anti-IL-17,  APC-conjugated anti-IFN-g, 
APC-conjugated anti-IL-10, PercP-conjugated anti-TNFalfa and APC-conjugated anti-
FoxP3 to score Tregs, according to the intracellular staining protocol for the 
Cytofix/Cytoperm kit (BD Bisciences).  The FlowJo Software was used for the off-line 
analysis. 
 
Pharmacological treatments 
In order to modulate T-cells CD39/CD73 activity, 50U/mL Apyrase (Sigma) was directly 
added to the cell cultures. In other samples, T-cells were preincubated with 30 ug/ml 
CD29 (integrin beta1 chain, BD), or with 200 uM periodate-oxidized 2′,3′-dialdehyde 
ATP (oATP) (Sigma) and rocked gently for 1.30 h at room temperature. T cells were 
then centrifuged and added to astroglia. Astrocytes were incubated with 2 uM 
Thapsigargin for 20‘, washed three times in PBS and incubated with T cells. T-cells 
cultured alone were incubated with the following drugs: 1-100 uM ATPϒS (Sigma), 100 
uM Bz ATP (Sigma) or with 10 ng/ml IL-6  for 24h. 
 
ELISA assay 
Cell supernatants were assayed for IL-6 or TNF-alfa production by a specific sandwich-
type enzyme-linked immunoabsorbent assay (ELISA) (DuoSet ELISA Development kit) 
according to the manufacturer‘s instructions (R&D System). Optical density (OD) values 
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(set to 540 nm or 570 nm) were plotted on a standard curve and expressed as pg/106 
cells recovered. 
 
Quantitative real-time RT-PCR (qPCR) 
CD4+ T cells were stained with an antibody against CD4 and CD45.2 and sorted by 
FACSaria (Beckton Dickinson). Total RNA was extracted using TRI REAGENT (Sigma) 
according to the manufacturer's instructions, including DNase I genomic DNA 
degradation step. RNA concentration was determined by Nanodrop. 1-2 μg of total RNA 
were reverse transcribed to generate cDNA, using high capacity cDNA reverse 
transcription kit (Applied Biosystems). Q-PCR was performed using Real Time Taqman 
universal master mix (Applied Biosystems) according to a standard protocol, using 25 
ng of template cDNA in a total volume of 10 ul. All primers were used at the final 
concentration of 900 nM. Q-PCR was performed using a Viia7 instrument (Applied 
Biosystem). The relative mRNA levels were calculated using the comparative Ct 
method, using GAPDH as a house keeping gene. 
 
Statistical analysis 
The statistical analysis between two groups of data was assessed using the two-tailed t-
Test, whereas the analysis of two or more groups was performed by using the one-tail 
ANOVA test followed by Tukeys post-hoc test. In some experiments two-way ANOVA 
test followed by Bonferroni post-hoc test was used to compare different treatment 
groups. Data was shown as means ± S.E.M. P<0.05 was considered significantly 
different. ****=p< 0.0001; *** = p<0.001; **= p<0.01; *= p<0.05. 
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AIM OF THE PROJECT 
 
 
Astrocytes are involved in many aspects of central nervous system (CNS) physiology and 
pathophysiology, including synapse formation and function, stimulation of neurite growth and 
branching, modulation of synaptic transmission and plasticity, regulation of blood–brain barrier 
(BBB) and myelination of axons. Whether and how astrocytes might be detrimental or protective 
during neuroinflammation has been intensely investigated with controversial results. The 
principal aim of my thesis was to dissect at the cellular and molecular levels the interaction of 
astrocytes with CD4 T helper cells, which play a pivotal role in shaping the adaptive immune 
response and can be responsible of immunopathological conditions, including multiple sclerosis 
and other neuroinflammatory processes. Adhesive contacts can be established between 
astrocyte and T cell, which may reciprocally influence the activity of the two cells. In addition, 
astrocytes and CD4+ T cells may communicate through secretion of signalling molecules during 
their cross-talk.   
Main objectives of this project were: 
1. To assess whether T cell activation modify adhesiveness to astrocyte and this in turn affect 
astrocyte function (e.g. Ca2+ signaling in astrocytes) 
2. To investigate the role and possible reciprocal regulation of purinergic signaling in activated 
T cells and astrocytes upon their interaction  
3. To dissect the dependence on cell-cell contact versus soluble mediators for phenomena 
occurring during astrocyte-T cell cross-talk 
4. To investigate the possible role of gap junctions and integrins in astrocyte-T cell 
communication 
5. To characterize transcriptional regulation and functional polarization of T cell upon 
interaction with astrocyte 
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RESULTS 
 
TCR stimulation enables CD4 T cell adherence to astrocyte. 
In order to characterize astrocyte/CD4+ T-cell interaction, we have co-cultured mixed 
mouse glial cells, containing both astrocytes and microglia, or purified astrocytes with 
either naïve or polyclonally activated CD4 T cells (previously stimulated with CD3 and 
CD28 antibodies for 40 h). CD4 T cells were plated on a glial monolayer at an astrocyte 
to T cell ratio of 1:2. Differential interference contrast (DIC) microscopy at 48 to 96 h 
after initiation of co-culture revealed a substantial fraction of activated but not naïve 
CD4+ T cells adhering to microglial cells or astrocytes. Figure 1 shows a representative 
picture of activated T cells co-cultured with mixed glial cells, in which microglia are 
stained with the myeloid marker isolectin IB4-FITC (left panel). As expected, activated T 
cells preferentially interacted with IB4 positive microglia, which are known to be 
professional antigen presenting cells (APCs). Nevertheless, several flatten CD4 T cells 
were found to adhere to the astrocyte monolayer, both when co-cultured together with 
glial cells and purified astrocytes (middle panel in figure 1).  Adherent T cells 
represented approximately 50% of total T cells in culture and maintained a stable 
interaction with astrocytes, which resisted several washing passages (data not shown). 
Conversely, unstimulated CD4 T cells did not establish direct physical contact with 
astrocytes and were confined in the floating cell fraction (right panel). 
 
 
 
 
 
 
 
Figure 1: Mixed glia or purified astrocyte-T cell co-culture. DIC image of mixed glial cell monolayer 
(left) or astrocyte purified monolayer (middle) co-cultured with activated T cell or purified astrocytes in the 
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presence of resting (unstimulated) T cell (right). Isolectin IB4 conjugated to FITC was used to label 
microglial cells. Scale bar 20 um. 
 
Astrocytes functionally interact with T cells although they display a low potential 
to act as professional APCs. 
Conflicting results have been published relative to the presence of MHCII and co-
stimulatory molecules in astrocytes [39, 169]. Indeed, while a large body of evidence 
indicates that activated microglia cells upregulate MHC-II on their surface both in vitro 
and in vivo [170, 171] ,  MHC-II expression has been reported in astrocytes in vivo only 
upon prolonged inflammation and in vitro after interferon-gamma (IFN- ) and Tumor 
Necrosis factor- alfa (TNF-α) treatment [36, 172]. Several papers reported that while 
having no influence alone on class II MHC expression, TNF-α enhances IFN-   induced 
class II MHC expression on astrocytes [173] [174].  Accordingly, we observed  that IFN-
  and TNF-α strongly up-regulated MHC-II, CD80 and CD86 expression in vitro, as 
indicated by flow cytometry analysis (figure 2A),  whereas exposure to IL17 and TNF-α 
or to LPS was ineffective. Altogether these findings confirmed and extended previous 
evidences supporting the crucial role of INF-  in promoting the antigen presenting 
capability of astrocytes by inducing upregulation not only of MHC-II but also of co-
stimulatory molecules. 
We next investigated the effect of CD4+ cells on MHC-II and CD80/86 expression by 
astrocytes. Immunofluorescence analysis showed that while astrocytes cultured alone 
do not express MHC-II, when cultured in the presence of activated CD4 T cells, they 
clearly expressed MHC-II on their surface (red staining, figure 2B). Flow cytometry 
analysis (figure 2C) confirmed MHC-II induction on astrocytes co-cultured with activated 
CD4+ T cells respect to astrocytes cultured alone or activated with LPS. Notably, 
unstimulated (resting) CD4+ T cells did not induce MHC-II expression on purified 
astrocyte (figure 2B, second panel). As shown in figure 2D, immunofluorescence 
analysis revealed that T cell were not as efficient as IFN-  added in culture in promoting 
CD80/86 expression, while flow cytometry (figure 2E) detected only a slight increase in 
CD86 expression on astrocyte after exposure to activated T cell. As a positive control of 
professional antigen presenting cells (APCs), T cells were co-cultured with peritoneal 
macrophages: the orange trace in the histogram shows that activated T cells 
significantly induced CD86 and to a lesser extent CD80 on macrophage surface.  
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We also investigated by immunohistochemistry whether MHCII expression could be 
detected on astrocytes in vivo, by analyzing the spinal cords of mice affected by 
Experimental Autoimmune Encephalomyelitis (EAE), the mouse model of human 
multiple sclerosis. Whereas strong MHC-II immunoreactivity was present in the vast 
majority of IB4+ microglial cells, we could detect only rare MHC-II positive astrocytes 
and we could rarely detect MHC-II in astrocyte plasma membrane (figure 2F). Overall 
our in vitro and in vivo data indicate that although astrocytes have the potential to act as 
APCs, they do not efficiently upregulate costimulatory molecules upon exposure to 
activated CD4+ T cells. Thus astrocytes are likely able to deliver a signal to T cells 
albeit with reduced strength than ―professional‖ APCs, which are characterized by 
higher density of MHC-II and CD80/86 on their surface. 
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Figure 2 : Analysis of cell surface protein expression by primary murine astrocytes after addition 
of activated CD4+ T cell. (A) MHC class II and costimulatory molecules (CD80 and CD86) on astrocytes 
were analyzed by flow cytometry in the absence (CTRL) and 72 h after the addition of LPS (400 ng/ml) or 
IFN-γ and TNF-alfa (25 ng/ml and 20 ng/ml, respectively) or IL17 and TNF-alfa (100 ng/ml and 20 ng/ml 
respectively). Representative histograms are shown. (B-C) Activated T cells induce MHCII-expression on 
astrocyte. Immunofluorescence and flow cytometry of MHC-II expression on astrocyte alone (left), co-
cultured with resting (middle) or activated T cells (right). Confocal images of astrocytes culture stained for 
the astrocyte marker  GFAP (blue), IBA1 (green) to detect microglial cells and MHC-II (red), DAPI for the 
nuclei (gray). Scale bar 50 um.  (D) Confocal images of astrocytes GFAP positive (red) double stained for 
CD80 or CD86 (green). Scale bar 25 um. (E). Histograms showing CD80 and CD86 expression by 
astrocyte cultured alone (blue line), astrocytes co-cultured with activated T cell (red line) or CD80/CD86 
expression by peritoneal macrophages upon T cell culture as positive control (orange line). (F) 
Immunostaining of spinal cord slices from EAE mice. Stage 2 of the disease. Astrocytes are positive for 
GFAP (green), microglial cells IBA1 positive (blue) and MHC-II molecules are shown in red. Scale bar 25 
um. 
 
 
 
 
Activated but not resting T-cells reduce spontaneous calcium oscillations in 
astrocytes. 
 
It is well known that cortical astrocytes display spontaneous [Ca2+]I oscillations both in 
culture [83, 84] and in acute brain slices [85, 86]. Moreover, such spontaneous 
increases in intracellular calcium concentration can occur in the absence of neuronal 
activities [175] [84] [87, 98] and are mainly caused by both extracellular Ca2+ influx and 
intracellular Ca2+ release from the endoplasmic reticulum (ER)[176]. Whether immune 
cells like CD4+ T cells can influence spontaneous calcium oscillations in astrocytes is 
unexplored to date. In order to address this point, astrocytes cultured alone or co-
cultured with activated T cells for 96 hours were loaded with the calcium sensitive dye 
Oregon green (figure 3A) and the percentage of cells showing spontaneous calcium 
transients were measured. We observed that while in astrocytes sample almost 40% of 
the total recorded cells exhibited spontaneous calcium transients, in astrocytes co-
cultured with activated T cells this percentage was  significantly reduced (figure 3A-B). 
Strikingly, co-culture with non-stimulated, resting naïve T cells did not affect the 
percentage of astrocytes displaying calcium oscillation (figure 3C).  
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Figure 3: Spontaneous intracellular calcium oscillation in astrocyte are downregulated by the 
presence of activated T-cells. (A, left panel) Representative fluorescence image of cultured astrocytes 
loaded with the calcium sensitive dye Oregon Green  (Fluorescence 505 nm). Regions of interest (ROIs) 
were drawn on the cytoplasmatic portion of all the cells present in the recording field (scale bar 20 um). 
Representative traces of spontaneous Ca2+ transients measured in astrocytes alone (middle panel) and 
in astrocytes cultured with activated  CD4+ T cells (right panel). (B-D) Quantitative analysis of the 
percentage of astrocytes displaying calcium oscillations under different conditions. (B) The percentage of 
cells exhibiting spontaneous calcium transients was significantly reduced in the presence of activated T 
cell (n exp= 4 ; n=64 fields astrocyte alone, n=62 fields astrocyte with T cells), but not in the presence of 
resting T cells (C), (n exp= 2 ; n= 33 fields astrocyte alone,  n=32 fields astrocytes with resting T cells). 
(Mean ± SD).  (D) Astrocytes treated with the ATP –degrading enzyme, Apyrase (30 U/ml) for 1 h 
displayed a significantly reduction of cells showing spontaneous calcium oscillation (n exp= 3 ; n= 27  
fields astrocyte alone, n=38 fields astrocyte Apyrase treated ) (Mean ± SEM). Statistical significance was 
evaluated with Student‘s t-test, ****p < 0.0001, **p < 0.01). 
 
 
Among soluble factors involved in the regulation of astrocyte calcium signalling, ATP is 
known to be one of the most important (Cortina et al. 2000, P.B. Guthrie 1999 J Neurosci). 
Moreover Koizumi S. and collaborators showed that application of apyrase, an ATP 
hydrolyzing enzyme able to convert ATP to ADP and AMP, abolished spontaneous 
Ca2+ oscillations in cultured hippocampal astrocyte, thus suggesting that spontaneous 
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Ca2 oscillations in astrocytes are tightly dependent on extracellular ATP levels [98]. 
Thus, we confirmed these observations by incubating cultures of cortical astrocytes for 
1 hour with 30 U/ml apyrase. Also in our experimental setting apyrase significantly 
reduced the percentage of astrocytes showing calcium oscillations (figure 3D). 
Altogether these results suggest that extracellular ATP plays an important role in the 
generation of spontaneous calcium transients in astrocytes and that activated CD4+ T 
cells might modulate spontaneous cytosolic Ca2+ elevations in astrocytes by affecting 
extracellular ATP levels.  
 
 
 
 
Reduction of extracellular ATP levels upon astrocyte-CD4 T cell contact. 
 
Among bioactive molecules secreted by astrocytes, ATP is a key messenger, which 
may signal to CD4+ T cell [42, 130]. ATP is released from astrocytes through gap 
junction hemichannels or through exocytosis of ATP-storing vesicles. Once released, 
ATP can activate purinergic ionotropic receptors present on neighbouring T cells [126, 
177], thus facilitating Ca2+ entry and consequently regulating T cells activation [178].  To 
explore the possible role of ATP signalling in astrocyte-T cell interaction, we evaluated 
whether ATP levels in the pericellular space of astrocyte were modulated by activated T 
cells. We performed the luciferin/lucyferase assay to determine ATP concentration in 
the supernatants of astrocytes cultures, T cells, and astrocytes together with activated T 
cells. Our data revealed a significant reduction of extracellular ATP level in astrocyte-T 
cell co-cultures (figure 4A). This result suggests that activated CD4 T cells either inhibit 
ATP release or hydrolyze extracellular ATP.  
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Figure 4: Detection of significantly reduced ATP level in astrocyte-T cell co-culture. (A) ATP content in 
the supernatants of astrocytes culture, mechanically stimulated astrocytes, T cells and astrocytes/T cells co-
culture detected by luciferase assay. Measurements were performed after 72 h of co-culture. Each sample 
was made in triplicate and measures were performed in KRH. N exp= 5; (Mean ± SEM). (B) ATP content in 
the supernatants of astrocytes , T cells and astrocytes/T cells co-culture in the presence of 100 uM ARL, an 
inhibitor of NTPDase1/CD39, for 72h.  n exp= 2; (Mean ± SD).  (C) Extracellular ATP in the supernatants of 
astrocytes co-cultured with T cells form WT or NTPDase1-/- (CD39KO) mice; n exp= 2; (Mean ± SD).  
Statistical significance was evaluated with Student‘s two tailed t-test, p**< 0.01 ****p < 0.0001.  
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A large body of literature reports that CD4+ T cells express on their surface 
ectoenzymes involved in the regulation of extracellular ATP levels: CD39, the dominant 
ectoenzyme in the immune system, converts ATP to ADP and AMP, whereas CD73 
converts AMP to adenosine [138] [139]. We thus investigated whether extracellular ATP 
reduction in astrocyte-T cell co-culture could be attributed to the activity of 
ectonucleotidases expressed by activated T cell. To address this point, we firstly 
measured extracellular ATP by the luciferin/luciferase assay in astrocytes incubated in 
the presence of ARL (100 uM), which partially but significantly inhibits NTPDase1/CD39 
activity. Histograms in figure 4B shows that pharmacological inhibition of CD39 
prevented the reduction of extracellular ATP observed in astrocyte-T cell co-culture. 
Moreover, we used the same assay to measure ATP in the supernatant of astrocytes 
co-cultured with CD4+ T cells isolated from NTPDase1-/- mice, in which the gene 
encoding CD39 is deleted (figure 4C). T cells lacking CD39 protein significantly reduced 
extracellular ATP levels, although to a lesser extent than wild type T cells. The lack of 
effect of NTPDase1-/- CD4 cells is likely due to residual ectonucleotidase activity 
provided by other enzyme isoforms expressed in T cells.  
 
 
Overexpression of ectonucleotidases in CD4 T cells upon astrocyte co-culture. 
 
To substantiate the hypothesis that CD39 and CD73 were induced in astrocytes/T cells 
co-cultures and they modulated extracellular ATP levels, we analyzed surface 
expression of CD39 and CD73 on CD4+ T cells in different culture conditions by 
confocal microscopy and flow cytometry. Immunofluorescence staining (figure 5A, right 
panel) revealed that T cells, identified by CD3 immunoreactivity (green), adhering to 
GFAP positive astrocytes (blue) clearly expressed CD39 and CD73 on their surface 
(red). Positive surface staining for both ectonucleotidases was also detected in a 
percentage of T cells cultured alone (figure 5A, left panel). Thus, flow cytometry allowed 
us to quantify the percentage of CD39 and CD73 positive CD4+ T cells and to evaluate 
possible changes in the expression level of these proteins on T cell surface upon 
astrocyte co-culture. 48 and 96 hours after astrocyte exposure (astrocyte: T cell ratio 
1:2 as previously described), CD4+ T cells floating on astrocytes and adhering to them 
were surface stained for CD4, CD45, CD39 and CD73 and then analyzed by FACS as 
described in materials and methods. Figure 5B shows a representative density plot of 
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CD39 /CD73 positive cells at different times of culture. We found that T cells adherent to 
astrocytes displayed surprisingly higher CD39 and CD73 surface levels compared to 
control T cells cultured alone. In detail, after 96h of co-culture, the percentage of CD39 
and CD73 positive cells increased from about 12% (among T cells cultured alone) to 47 
% (among T cells adhering to astrocytes) for CD39 and from 49% to 86% for CD73. 
Moreover, T cells adhering to astrocytes displayed a progressive increase of CD73 
positive cells over time also, both among suspended or adherent T cells. In T cells 
adhering to astrocytes, number of CD73 positive cells increased from 75% CD73 
positive detected at 48h to 86% at 96h of co-culture (right panel, figure 5B). The 
histogram in figure 5C well represents the effect mediated by astrocyte on CD39 and 
CD73 induction on suspended (orange line) or adherent (red line) T cells. These results 
indicate that contact with astrocyte results in strong upregulation of both 
ectnucleotidases in T cells. 
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Figure 5: CD39 and CD73 were significantly upregulated in T cells adhering to astrocyte. (A) 
Immunofluorescence staining of T cells alone (left) or T cells co-cultured with astrocyte (right) labelled 
with CD3 (green) to stain T cells, GFAP to visualize astrocytes (blue) and with CD39/CD73 (red). DAPI 
for the nuclei (gray). Scale bar 25 um (B) Representative density plot of the percentage of CD39 /CD73 
positive cells after 48 h (higher panel) or 96 h (lower panel) of co-culture. Numbers reported in dot plots 
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indicate the percentage of CD39/CD73 positive cells within the quadrant. (C) Histograms representative 
of CD39/CD73 induction on T cells floating or adhering to astrocyte respect to T cells alone. 
 
Mean fluorescence intensity (MFI) of T cells either floating or adherent to astrocytes 
was used as reference parameter to reveal possible changes in ectonucleotidase 
expression under different culture conditions. MFI values, normalized on T cells cultured 
alone and measured on the CD39/CD73 total population, revealed that CD39 
expression increased by 5 fold in T cells physically associated to astrocytes, while 
CD73 increased more than 6 fold in adherent T cells respect to T cells alone (figure 5D). 
Moreover, no significant increase in CD39 expression was detected in suspended T 
cells, while CD73 expression increased by 4 fold in floating T cells respect to the 
control. Accordingly, the percentage of CD39 and CD73 positive cells was significantly 
higher  in T cells adhering to astrocytes as compared to floating T cells (figure 5E). We 
also evaluated ectonucleotidases expression on astrocyte surface (figure 5F). In line 
with previous observations [179, 180] astrocytes were positive for both CD39 and 
CD73. However, we did not observe significant changes of CD39 and CD73 expression 
in astrocytes alone respect to astrocytes exposed to activated CD4 T cells. 
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Figure 5: CD39 and CD73 were significantly upregulated in T cells adhering to astrocyte. (D-E) 
Analysis of CD39/CD73 relative MFI  (measured on the total population) (left) and the percentage of 
positive cells (right)  measured by FACS after 96h of co-culture with astrocytes. N exp = 5. Data are 
expressed as the MFI ± SEM and compared by Anova one way test with Tukey‘s multiple comparison 
post test. Values are normalized on T cells alone.p*< 0.05, p**< 0.01, p***< 0.001 . (F) Analysis of CD39 
and CD73 expression by astrocytes in flow cytometry.  
 
 
Selective CD73 induction in  activated T cell by contact with astrocyte 
 
 
To investigate whether CD39 and CD73 induction on T cells was a specific feature of 
astrocytes, we co-cultured CD4+ cells with peritoneal macrophages or with microglial 
cells, at the same cell to cell ratio (APCs :T cells ratio of 1:2). A similar upregulation of 
CD39 (by about 5 fold) to that one detected after astrocyte exposure, was detected on T 
cells adhering to macrophages or microglia (figure 6A, upper panel), with 50% of total T 
cells becoming CD39 positive 96h after microglia or macrophages co-culture (not 
shown). On the contrary, the percentage of CD73 positive T cells contacting microglia or 
macrophages was not significantly different from T cells cultured alone (figure 6B, lower 
panel). In fact, exposure to macrophages or microglia resulted in significantly lower 
percentage of CD73 positive T cells with respect to astrocyte co-culture (figure 6B lower 
panel). Moreover, CD73 MFI of T cells co-cultured with macrophages or microglia was 
similar to the MFI of T cells cultured alone (figure 6A lower). Altogether these data 
indicate that CD73 is selectively upregulated in previously activated CD4 cells upon 
contact with astrocytes but not professional APCs. 
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Figure 6: Astrocyte-specific CD73 induction on T cells. (A-B) Histograms represent the percentage or 
MFIs values calculated on CD39/CD73 positive or total T cell population respectively, cultured with 
astrocytes/ macrophages/ microglia. Values are normalized on T cells alone (not show). n exp= 5 
(astrocytes); n= 3 (microglia); n= 2 (macrophages MFI ± SD) . Data are expressed as the MFI ± SEM and 
compared by Anova one way test with Tukey‘s multiple comparison post test.  p*< 0.05 
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Astrocyte contact-dependent downregulation of CD4. 
 
 
Astrocytes promote downregulation of TCR expression and suppress upregulation of 
CD25 upon T-cell activation [181]. We observed a similar downregulation of the CD4 
co-receptor in activated T cells upon contact with astrocytes, macrophages or microglia. 
The histograms and dot plot in figure 7A (lower panel) clearly shows that T cell cultured 
alone or suspended on astrocytes monolayer expressed high levels of the CD4 receptor 
on their surface. Conversely, T cells contacting  astrocytes completely downregulated 
the co-receptor. To investigate whether CD4 molecules were internalized after contact, 
we performed intracellular staining of T cell. Figure 7B shows that CD4 was actually 
internalized in T cells adhering to the astrocyte monolayer. Nevertheless, this effect was 
not astrocyte-specific and in line with the literature we observed the same CD4 
downregulation also in T cells contacting  peritoneal macrophages and microglial cells.  
 
 
                                                                                    
 
 
Figure 7: CD4 receptor is downregulated after astrocyte- contact. (A) Histograms (upper panel) and dot 
plot (lower panel) show different CD4 co-receptor levels in T cells alone, suspended or adherent to 
astrocyte (red line). The blue line represents Isotype control. (B) T cells adhering to astrocyte were 
permeabilized and stained for CD4 to detect intracellular CD4. Blue line represents Isotype control. 
CD4 expression
A                                                                                       B
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Physical cell contact mediates CD39/CD73 upregulation on CD4+ T cell 
Stronger induction of ectonucleotidases in T cells adherent to astrocytes as compared 
to floating T cells suggested that physical cell contacts may play a relevant role in the 
process. To definitely assess the role of cell-to-cell contact in CD39 and CD73 induction 
in astrocytes-T cells co-cultures, CD4+ lymphocytes were separated form astrocytes in 
the co-culture by a 0.3 M membrane of transwell system. Analysis in flow cytometry 
both at 48h and 96h (not shown) revealed that CD39 and CD73 upregulation was 
completely abrogated on T cells separated from astrocytes by transwell (figure 8). This 
result strongly support the notion that cell-to-cell contact could be crucial in regulating 
ectonucleotidase expression in T cells by astrocytes. Nevertheless, the transwell 
system beside avoiding physical contact of T cells with astrocytes may also prevent T 
cell activation by labile soluble factors such as nucleotides triphospate produced by 
astrocytes, which might influence expression of the ectonucletidases. This could be 
especially true for CD73 expression, which is induced by exposure to astrocytes but not 
to APCs.  
 
 
 
 
 
Figure 8: Astrocyte/T cell contact and Il-2 cytokine are critically involved in CD39/CD73 induction. (A) 
FACS analysis of CD39 /CD73 expression in T cells separated from astrocytes by transwell (0.3 uM 
membrane pore) for 48h. 
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Lack of evidence for gap junctions mediated interaction between astrocytes and 
CD4+ T cells. 
 
To elucidate the nature of astrocyte-T cell interaction we focused on the possible 
molecules responsible for their reciprocal contact. Both T cells and astrocytes express 
proteins of the connexin and pannexin families (Cx32, Cx43, Cx30, pannexin1), which 
form membrane hemichannels that mediate release of signalling molecules into the 
pericellular space [41-43]. Through formation of intercellular channels, called gap 
junction, connexins also allow the direct transfer of signaling factors between adjacent 
cells including cAMP, Ca2+, adenosine-5-triphosphate (ATP), inositol 1,4,5- 
trisphosphate and morphogens [45]. Notably, recent studies showed that T cells may 
form heterotypic gap junction with adjacent dendritic cells [182]. To investigate possible 
formation of gap junction between astrocytes and T cells, astrocytes were loaded with 
Calcein AM 1 uM, a gap junction permeant green fluorescent dye, and then co-cultured 
with CD4+ activated T cells. Calcein AM is readily retained in the cytosol after the 
acetoxymethyl ester is cleaved by intracellular esterases. The resulting compound has a 
molecular weight of 520 Da, and thus is able to pass through gap junctions. After 
astrocyte loading, we analyzed possible dye transfer from astrocytes to T cells by flow 
cytometry, a technique which allows a precise evaluation of the amount of transferred 
dye in recipient cells through the analysis of MFI. After 24 and 48 hours no dye transfer 
from astrocyte to T cell in the co-culture was detectable (figure 10), suggesting that gap 
junctions (GJs) were not formed between the two cell types. As positive control, CD4+ T 
cells were co-cultured with peritoneal macrophages, which, according to literature, form 
GJs with T cells [182]. Already after 24h of co-culture with peritoneal macrophages, 
CD4+ T cells took up significant amount of the fluorescent dye. Histograms in figure 10 
show a significant increase in MFI of T cells co-cultured with calcein AM loaded 
macrophages, while MFI of T cell co-cultured with calcein AM loaded astrocyte did not 
change with respect to T cells cultured on astrocytes labeled by CMFDA as control. 
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Figure 10: Lack of gap junctions detection between astrocyte and T cell. Direct intercellular 
communication through gap junction channels was assessed using flow cytometry by measuring the 
amount of calcein AM (1 uM) transferred from astrocytes or peritoneal macrophages (as positive control), 
to lymphocytes after 48 h of co-culture. 
 
 
 
B1 integrin participates to astrocyte-T cell contact  
Searching for adhesion receptors that could mediate T cells adhesion to astrocytes and 
consequently contribute to CD39 and CD73 upregulation in T cells, we focused on 
integrins. Indeed, previous studies demonstrated that beta1 integrin plays an important 
role in the epithelial/T-cell and astrocyte/ T cell interaction [46-49]. The group of 
Colombatti M. discovered that alfa3/beta1 integrins are active components of the 
molecular complex mediating astrocyte / T cell binding and another group showed that 
the subunits of VLA-4 integrin, alfa4/beta1, are necessary for T cell contact-induced 
generation of proinflammatory molecules in astroglia. Thus, we investigated the role of 
beta1 integrin in astrocyte/T-cell adhesion by assessing whether a beta1 blocking mAb 
affected ectonucleotidases upregulation on T cells. First, FACS analysis revealed that 
activated CD4+ T cells, upon astrocytes contact, expressed on their surface beta1 but 
not alfa4 integrin subunit (figure 11A). Incubation of T cells with the beta1 blocking mAb 
(figure 11B) resulted in reduced CD39 expression, albeit non-significantly, in T cells that 
adhered to astrocyte (figure 11C). We did not detect changes in CD39 expression on T 
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cells suspended on astrocytes, or in CD73 expression on T cells either suspended or 
adherent to astrocytes. These results indicate that CD39 upregulation depends at least 
in part on integrin-mediated physical contact between astrocyte and T cell. 
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Figure 11: The role of beta1 integrin in CD39/CD73 expression in T cells co-cultured with 
astrocytes. (A) Density plot of beta1 and alfa4 integrins expression on activated T cells alone or 
contacting astrocytes. (B) Incubating T cells for 1.30 h with anti-beta1 integrin mAb (30 ug/ml) blocks 
beta1 integrin binding sites (right). Site inhibition was evaluated by FACS staining with PE coniugated 
anti-beta 1 integrin mAb (C) Incubation with anti-beta1 integrin (30 ug/ml) mAb partially prevented CD39 
induction on T cells adhering to astrocytes (expressed as MFIs calculated on total T cell population). No 
observable changes in CD73 expression. Values are normalized on T cells alone (not shown). N exp = 3. 
Data are expressed as the MFI ± SEM and statistical significance was evaluated with Student‘s two 
tailed t-test.  
 
 
ATP plays an important role in CD39  upregulation on T cell adhering to astrocyte. 
Overall data obtained until now suggested that the interplay between astrocyte and T 
cell is crucial in CD39/CD73 upregulation. Our results excluded that this interaction 
could be mediated by gap junctions and, in line with previous findings, we observed that 
integrin beta1 is involved in astrocyte-T cell adhesion. Moreover data obtained by 
transwell experiment revealed that physical contact with astrocytes is of absolute 
importance for ectoenzymes induction on T cell surface. However, these experiments 
did not exclude that soluble factors and short-range acting molecules released by 
astrocyte may contribute in ectonucleotidase induction. Among soluble molecules, 
extracellular nucleotides and in particular adenosine triphosphate (ATP) could be 
significantly involved in this mechanism.  In order to verify this hypothesis, we incubated 
astrocyte/T cell co-culture with the ATP degrading enzyme Apyrase, which converts ATP 
to ADP and AMP. After 48h we analyzed ectoenzymes levels on T cells surface in flow 
cytometry. In the presence of Apyrase at 50 U/ml, we observed a reduced increase in 
CD39 on T cells which adhered to astrocytes, while CD73 MFI was unchanged (figure 
12A). This result suggested an important role of extracellular ATP in CD39 induction on 
T cells. To further support this conclusion, we pre-incubated T cells with the P2X 
antagonist periodate-oxidized 2′,3′-dialdehyde ATP (oATP) to pharmacologically prevent 
extracellular ATP sensing by the T cell. Histograms in figure 12B show that oATP 
reduced CD39 increase on T cells contacting astrocytes, while had no effect on T cells 
floating on astrocyte or on CD73 expression. To directly evaluate the contribution of 
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ATP on ectoenzyme upregulation we incubated CD4+ cells for 24 (figure 12C) and 96h 
(not shown) with ATP-S, a non-hydrolyzable phosphorothioate ATP analog that  cannot 
be hydrolyzed by ATPase, or with the prototypic P2X7 agonist 2′(3′)-O-(4-
benzoylbenzoyl) ATP (BzATP). Although ATP seems to be crucially involved in CD39 
upregulation in T cells/astrocytes co-culture, T cells incubation with either agonist per se 
did not result in significant CD39 or CD73 induction on T cells (figure 12C), thereby 
suggesting that other factors during T cell/astrocyte interaction enables the purinergic 
signaling, which contributes to CD39 upregulation. 
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Figure 12: CD39/CD73 induction is partially dependent on extracellular ATP levels. (A) Histograms 
show flow cytometric analysis of CD39/CD73 MFIs calculated on total T cells population in the presence 
of Apyrase (50 U/ml) in the co-culture, n exp= 2 (Mean ± SD) or (B) preincubating T cells for 1.30 h with 
oATP (200 uM) n exp = 4  (Mean ± SEM). (C) CD4+ T cells cultured for 24 h in the presence of ATP-S 1 
/ 100 uM  or with BzATP 100 uM.  MFIs are measured on total T cells. Statistical significance was 
evaluated by Student‘s two tailed t-test (A-B) and by Anova one way test with Tukey‘s multiple 
comparison post  test (C). 
 
 
Inhibition of astrocytic spontaneous calcium waves by tapsigargin completely 
prevent CD73 induction. 
As already mentioned in the introduction, astrocytes are able to communicate one with 
each other thorough spontaneous intracellular calcium [Ca2+]i waves [80, 81]. It is also 
known that astrocytic Ca2+ oscillations can trigger the release of several soluble factors 
called gliotransmitters, in a process named ―gliotransmission‖. The gliotransmitters 
released by astrocytes comprise glutamate [56, 89], D-serine [90], tumor necrosis factor 
alfa (TNFa) [91] and ATP [92, 93]. We therefore investigated whether spontaneous 
calcium waves in astrocytes are involved in CD39/CD73 upregulation on T-cells. In 
order to address such point, we took advantage of an irreversible inhibitor of 
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sarco/endoplasmic reticulum Ca2-ATPase pump (SERCA), thapsigargin, to deplete the 
intracellular store of calcium in the endoplasmic reticulum of astrocytes. Thapsigargin 
treatment can inhibit spontaneous Ca2+ oscillations for over 2 days even after the drug 
was washed away (figure 13A). 
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Figure 13: T cells contacting astrocytes in which Ca2+ signals were pharmacologically inhibited 
show basal CD73 expression level. Astrocyte monolayers were treated with thapsigargin (2 uM) for 20 
min and then  washed three times with PBS. The thapsigargin-treated astrocytes remained Ca 2+ signal-
deficient for at least 48 h after the withdrawal of the drug  (A). Representative density plot of CD39/CD73 
induction at 48h on T cells adhering (B) or suspended (C) on thapsigargin-treated astrocytes. (D) T cells 
cultured alone. (E) Histogram shows CD73 expression on adherent T cells. N exp=2 
 
 
Thus, activated T cells were co-cultured with thapsigargin-pretreated astrocytes and 
after 48h ectonucleotidases expression in T cells was evaluated by FACS analysis. We 
found that CD73 expression level on both adherent (figure 13B) and suspendend (figure 
13C) T cells cocultured with thapsigargin-pretreated astrocytes was comparable to 
CD73 expression level measured in T cells cultured alone (figure 13D), indicating that 
the inhibition of spontaneous calcium oscillation in astrocytes completely prevented the 
upregulation of CD73. This result strongly suggested that a putative soluble factors 
released by astrocytes through a calcium-mediated mechanism might be critical for the 
upregulation of ectonucleotidases observed in T-cells. 
 
 
 
Increase in TNFalfa  and IL6 secretion in astrocyte-T cell co-culture. 
The list of cytokines produced by astrocytes in vitro and/or in vivo comprises interleukin 
(IL)-1; IL-6; IL-10; interferon (IFN)-a; IFN-b, tumor necrosis factor (TNF)-a; transforming 
growth factor (TGF)-b; colony-stimulating factors GM-CSF, M-CSF, and G-CSF; and 
chemokines, including RANTES, IL-8, monocyte chemoattractant protein-1 (MCP-1), 
and IFN-g-inducible protein-10 (IP-10)  [39]. Among other cytokines, IL-6 can be critical 
in the maintenance or limitation of focal inflammatory processes owing to its ability to 
regulate the survival/expansion of lymphocytes and the development/differentiation of 
astrocytes, which invariably develop reactive gliosis during infective/degenerative 
diseases of the CNS [183]. IL-6 gene expression is regulated in different tissues by a 
variety of effectors molecules, including those involved in adhesive interactions 
(i.e.,integrins) [184]. Myelin basic protein (MBP)-specific clonal T cells are able to 
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induce IL-6 gene expression in U251 astrocytes both by release of soluble factors and 
adhesion [48]: through astrocyte induction, T cells may indirectly regulate the availability 
of a cytokine crucial in modulating fate and behavior of cell populations involved in the 
pathogenesis of MS inflammatory lesions. We therefore measured IL-6 and TNF alfa 
levels in T cells, astrocytes and in astrocyte-T cell co-culture. In line with previous 
finding, we detected significantly higher TNFalfa (14A) and IL-6 (14B) levels in 
astrocyte-T cell co-culture respect to astrocyte or T cell alone. A peak of IL6 production 
was observed after 96 hours of co-culture, time at which we detected the greater CD73 
induction on T cell. To understand whether a link between cell contact, IL6 production 
and ectoenzymes upregulation on T cells could exist, we stimulated activated T cell with 
IL6 (10 ng/ml), and subsequently analyzed CD39/CD73 expression on T cells. After 24h 
(figure 14C) and 96h (not shown) of IL-6 stimulation we did not observe any change in 
CD39 and CD73 expression on T cell, thus excluding a major role for this cytokine in 
ectoenzymes induction on T cells.  
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Figure 14: IL-6 and TNFalfa production in astrocyte/T cell co-culture. (A-B) Quantification of TNFalfa 
and  IL-6 by ELISA in culture supernatants of astrocytes, T cells and astrocytes/T cells co-culture at 
different times (24, 48, 72, 96 h). Histograms represent the average of duplicates obtained in two 
independent experiments  (Mean ±SD). (B) Relative CD39/CD73 MFI obtained in flow cytometry on CD4 
T cells incubated with IL-6 (10 ng/ml) for 24h. Values are normalized on T cell alone. 
 
 
Transcriptional Th17 signature in T cell adhering to astrocyte. 
Interleukin-17 producing T cells (Th-17 cells) represent a distinct lineage of CD4+ T 
cells that can differentiate from uncommitted naive T cell precursors under the aegis of 
the transcription factors RORgt and RORa and the polarizing cytokines transforming 
growth factor-b, IL-6 and IL-23 [155, 185]. Ghiringhelli‘s group has recently described 
Th17 cells generated with the polarizing cytokines IL-6 and TGF-b, which express CD39 
and CD73 ectonucleotidases and suppress effector T cells likely through adenosine 
generation [159]. Transcritptional regulation of ectonucleotidases was dependent on IL-
6-driven Stat3 activation and TGF-b-mediated downregulation of zinc finger protein 
growth factor independent-1 (Gfi-1). In order to define whether activated T cells co-
cultured with astrocytes and in particular adherent T cells, may acquire an effective 
regulatory or inflammatory phenotype, we performed real time PCR (qPCR) for markers 
of distinct T cell phenotypes on both floating and astrocytes-adherent CD4+ T cells at 
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48 h of co-culture. Transcriptional regulation of master switches for T cell functional 
skewing, including Tbet for T helper Th1 cells, GATA3 for Th2, RORC for Th17 cells 
and Foxp3 for Tregs was investigated on sorted CD4 cells. We found that Rorc mRNA 
was specifically induced in T cell adhering to astrocyte, as compared to T cell alone, but 
not in floating cells (figure 15A). Moreover Rorc transcription was completely prevented 
by separating astrocyte and T cell by culture in transwell. RorC was specifically induced 
in T cells adherent to astrocytes since we did not observe significant changes in RorC 
transcription rate in T cells co-cultured with peritoneal macrophages (figure 15B). 
 
                                                                              
 
Besides transcription factors, intracellular staining with relevant cytokine-specific 
antibodies was performed to assess the effector potential of T cells (figure 15C). After 
48h of co-culture accordingly with  RorC upregulation, astrocytes-adherent T cells 
displayed a significant increase in intracellular IL17 production respect to T cells alone. 
Furthermore, adherent CD4+ T cells showed increased intracellular IFNgamma respect 
to T cells alone. This result is highly coherent with previous data which have 
demonstrated that astrocytes promote the generation of IFN-g and IL-17 citokines in 
concanavalin A- and myelin basic protein-stimulated lymph node cells from rats [186]. 
We also observed that TNFalfa levels increased more than half both in suspended and 
adherent T cells. We did not observe detectable changes in IL10 production, and in 
FoxP3 trasncription. 
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Figure 15: Increase in Rorc transcripts (Th17 program) in T cells adhering to astrocytes. (A) qRT-PCR 
analysis indicated no significant changes in mRNA levels of the transcription factors Tbx2 coding for Tbet 
(Th1 program), GATA3 (Th2 program) and FoxP3 (T regulatory phenotype) in activated T cells both 
floating and adhering to astrocytes respect to activated T cells alone after 48h of co-culture. mRNA 
expression was quantified by RT-PCR in 2 independent experiments. mRNA levels of the different genes 
were first normalized to the GAPDH housekeeping gene, and then expressed relatively to the levels 
found in CD3/CD28 activated control T cells. Statistical significance was analysed by two-way ANOVA 
test with Bonferroni post test (mean ±SD). (B) Analysis of transcription factors expressed by T cells co-
cultured with peritoneal macrophages (n= 1). (C) Flow cytometry analysis of the intracellular cytokines:  IL17, 
IFNgamma, TNFalfa, IL10 and the transcription factor FoxP3 in CD4+ cells in the indicated culture conditions. 
Rapresentative dot plot.  
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DISCUSSION 
 
Astrocytes, the most abundant cells into the brain, play a crucial role in CNS function 
both in normal and pathological conditions [56, 57] [58, 59] [60] [61]. Together with 
endothelial cells, astrocytes are closely apposed to the blood brain barrier (BBB), and 
constitute the glia limitans, which regulate immune cells entry into the CNS [39]. 
Disturbed integrity of BBB and massive infiltration of leukocytes are important features 
in the pathogenesis of many neuroinflammatory diseases, such as multiple sclerosis 
(MS) and its animal model experimental autoimmune encephalomyelitis (EAE) [1] [2]. 
The role of leukocytes in promoting astrocyte capacity to present antigen to T cells and 
initiating production of pro- and anti-inflammatory mediators has been addressed in a 
number of studies with controversial results [39, 174, 187]. Astrocytes represent a 
source of various cytokines relevant for maintenance and/or regulation of the 
inflammatory response within the CNS [50]. However, whether and how astrocytes 
might play a protective or detrimental role during CNS inflammation has not been 
elucidated yet. The essential aim of my thesis was to contribute knowledge into the 
reciprocal interaction of astrocytes with activated CD4+ T helper cells, which play a 
pivotal role in the initiation of CNS infiltration by inflammatory leukocytes in 
neuroinflammation.  
Astrocytes are non-excitable cells, nevertheless, one of their principal regulatory 
pathways is based on intracellular Ca2+ oscillations [80-82], which could be both 
spontaneous or evoked by neuronal activity. Our experiments revealed that astrocytes 
cultured in the presence of activated CD4+ T cells display significantly reduced 
spontaneous basal calcium oscillations. Previous T cell activation was crucial in 
endowing T cells with the potential to inhibit astrocytes Ca2+ oscillations since 
unstimulated  CD4+ T cells did not showed the same effect. Adenosine triphosphate 
(ATP) is one of the main extracellular mediators involved in the regulation of calcium 
signaling in astrocyte [92, 93]. Koizumi and collaborators convincingly demonstrated 
that not only neuronal evoked, but also spontaneous Ca2+ oscillations are tightly 
dependent on extracellular ATP [98] [188]. In agreement with previous observations, we 
showed that incubation of astrocytes with Apyrase (30 U/ml), an ATP hydrolyzing 
enzyme able to convert ATP to ADP and AMP, significantly reduced the percentage of 
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astrocytes showing basal calcium oscillations. We hypothesized that the reduction in 
calcium transients detected in astrocyte/T cell co-cultures could be directly linked to the 
modulation of extracellular ATP levels performed by T cells. In fact, experiments with 
luciferin–luciferase based assay showed a decrease in extracellular ATP concentration 
in astrocytes culture medium when activated T cells were present. This result 
represents the first evidence that ATP is an extracellular mediator which play a key role 
in the interaction between astrocyte and activated CD4+ T cell. We therefore postulate 
that activated CD4+ T cells might respond to and hydrolyze ATP released by astrocytes 
through the expression of ectonucleotidases. Notably, the plasma membrane 
ectonucleotidase CD39 (E-NTPDase1) is the dominant ectoenzyme in the immune 
system [138] that dephosphorylates  ATP to AMP by removing one phosphate at a time 
with modest residual ADP detectable [139]. In addition, T cells can express  CD73, a 
glycosyl phosphatidylinositol-anchored enzyme [140] that hydrolyses AMP to 
nucleosides (adenosine) and Pi. These two ectonucleotidases are characteristically 
expressed by  immunosuppressive Foxp3+ T regulatory (Treg) cells and their activities 
were hypothesized to be crucial for Treg cells mediated immune tolerance [147, 149]. A 
first indication for the involvement of ectonucleotidases activity in T cell mediated 
modulation of Ca2+ transient in astrocytes came from the observation that ARL 67156, 
which partially but significantly inhibits NTPDase1/CD39 activity, prevented the 
reduction of extracellular ATP detected in our astrocyte-T cell co-culture system. We 
therefore investigated the expression of ectonucleotidases in T cells cultured with or 
without astrocytes. FACS experiments revealed that activated CD4+ T cells co-cultured 
with purified astrocytes robustly upregulated CD39 and CD73 expression on their 
surface. CD4 T cells adhering to astrocytes displayed a surprisingly elevated increase in 
the percentage of CD39/CD73 double positive T cells as compared to the T cell 
population floating on astrocytes. We could not rule out whether suspended T cells 
previously or less intensely adhered to astrocytes, nevertheless this finding suggests 
that astrocyte contact might be required for ectonucleotidases upregulation on the 
surface of activated CD4+ T cells. 
In order to assess the selective role of astrocyte in CD39/CD73 induction on T cells, we 
co-cultured T cells with different antigen presenting cells (APCs), namely microglial cells 
(CNS resident APCs) and peritoneal macrophages, and analyzed CD39 and CD73 
expression in T cells by FACS. Whereas CD39 was induced on adherent T cells to a 
similar extent by all three cell types, CD73 was selectively upregulated upon contact 
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with astrocytes but not with other APCs. This result demonstrates the selective role of 
astrocytes in inducing CD73 ectonucleotidase on T cells. Furthermore it suggests the 
existence of an astrocyte-T cell contact dependent cross-talk based on the induction of 
ectonucleotidase activity in T cells and the reciprocal modulation of ATP signaling in 
astrocytes. In fact, impeding direct contact between astrocyte and T cell by a transwell 
culture system, CD39/CD73 upregulation in T cells was completely prevented. So far 
we postulate that physical contact with astrocytes is crucial for ectoenzymes induction 
on T cells.  
We could eventually demonstrate that astrocyte/T cell communication was not mediated 
by gap junctions formation, therefore we addressed whether integrin-mediated adhesion 
was involved in astrocyte-dependent ectonucleotidases upregulation in T cells. Previous 
data showed that integrins are indeed implicated in astrocyte/T cell binding. In 
particular, alfa3/beta1 integrins were shown to be the active components of the 
molecular complex mediating astrocyte-T cell interaction [48],  whilst the alfa4/beta1 
dimer was necessary for T cell contact-induced generation of proinflammatory 
molecules in astroglia [49]. We investigated whether blocking beta 1 integrin would 
affect ectonucleotidases upregulation on T cells in a similar way as observed in the 
transwell culture. In spite of substantial effect of beta1 integrin blockade on CD39 
expression, CD73 upregulation was not affected. Therefore, we concluded that direct 
cell–cell contact partially involving integrin beta 1 is required for  CD39 induction on T 
cells adhering to astrocytes. 
It is worth pointing out that the transwell system employed to address the cell-cell 
contact dependence for CD39/73 upregulation in T cells, beside avoiding physical 
contact between T cells and astrocytes, might possibly prevent T cell conditioning by 
labile soluble factors and/or short-range acting molecules released by astrocytes. We 
cannot therefore exclude that soluble molecules acting in the very pericellular space 
might contribute to ectonucleotidases induction on T cells. Astrocytes are indeed 
secretory cells able to release chemical transmitters in response to various stimuli in a 
process called ―gliotransmission‖ [56, 89] [90] [91] [92, 93] and ATP could well conform 
to the kind of mediators involved in this activity. Astrocytes are considered the main 
source of physiologically released ATP in the CNS [93]. Astrocytes can release ATP (1) 
by a Ca2+-dependent exocytosis [111-113] (2) by a regulated form of exocytosis,(3) 
through hemichannels formed by connexins and pannexins, and finally (4) through 
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plasmalemmal voltage-dependent anion channels and purinergic receptor (P2XRs) 
[109, 114]. We addressed whether extracellular ATP contributed to ectonucleotidases 
upregulation in T cell upon contact with astrocyte. Addition of Apyrase to astrocyte-T 
cell co-culture or pre-treatment of T cells with the P2XRs antagonist oATP before 
culture with astrocytes (thus inhibiting ATP mediated signaling by P2XRs in T cells), 
both independently resulted in substantial inhibition of CD39 upregulation. Although 
extracellular ATP appeared involved in astrocyte mediated CD39 induction, the 
incubation of T cells with a non-hydrolyzable ATP analog, ATPS, or with the prototypic 
P2X7 (the main P2X receptor subtype expressed in T cell) agonist BzATP did not result 
in significant increase of surface CD39. Altogether these data point to a role of 
pericellular ATP in regulating CD39 expression in adherent T cells in the context of 
astrocyte/T cell co-culture. Accordingly, the increase in surface CD39 was barely 
evident in non-adherent, i.e. floating, T cells. It will be interesting to investigate whether 
microglia and macrophages, which can both release ATP, induce CD39 upregulation 
upon contact with T cells by the same purinergic signaling pathway. 
In contrast to CD39, CD73 expression was selectively induced by T cells exposure to 
astrocytes but not to microglia and peritoneal macrophages.  As mentioned above, 
peculiar of astrocytes is the release of gliotransmitters triggered by spontaneous and 
neuronal activity-evoked Ca2+ oscillations. The actually known gliotransmitters include, 
further ATP[92, 93],  glutamate [56, 89] and D-serine [90]. To address whether blockade 
of Ca2+ signaling in astrocytes affected CD73 modulation in T cells, we depleted the 
intracellular calcium store in astrocytes ER by thapsigargin, an irreversible inhibitor of 
sarco/endoplasmic reticulum Ca2+-ATPase pump, which abolish cytosolic Ca2+ 
elevations. This treatment completely prevented CD73 upregulation induced in both 
adherent and suspendend T cells, thus suggesting that a Ca2+ dependent, possibly 
soluble, factor was responsible for this effect.  We are currently investigating which 
gliotransmitter could be critical in inducing CD73 upregulation in T cells.  
An important aspect of astrocyte/T cell interaction for CNS pathophysiology emerging 
from our study stems from the role of CD73 in regulating BBB permeability. Indeed, 
extracellular adenosine generated by CD73 activity promotes T cell infiltration into the 
brain during EAE, while blockade of the A2A adenosine receptor inhibits BBB crossing 
by T cells [7]. Accordingly, mice lacking CD73, which are unable to hydrolyze 
extracellular AMP to adenosine, were protected from EAE [8]. The correlation between 
astrocyte contact and CD73 upregulation on activated T cells  could  be important  to 
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assess a possible pathogenetic significance of astrocytes activity in leukocytes 
infiltration of the brain.  
Moreover, we detected IL-6 and TNF-alfa levels in astrocyte-T cell co-culture, which 
were significantly higher with respect to astrocyte and T cell cultured alone. Astrocytes 
represent the major source of IL-6 in the CNS [189]; elevated IL-6 levels are detected in 
injury, infection, stroke, and a wide range of CNS disorders, including MS, where IL-6 
could be detrimental as evidenced by the finding that IL-6 knockout mice are not 
permissive to EAE [190]. The coordinate regulation of IL-6 and CD73 might generate a 
pro-inflammatory environment permissive to leukocyte infiltration into the brain. 
Accordingly, analysis of T cell polarization in astrocyte/T cell co-culture revealed 
skewing of T cells toward IFN- and IL-17 secreting Th1 and Th17 phenotypes, which 
are both crucially involved in MS pathogenesis. Astrocytes selectively induced in 
adhering T cell high levels of Rorc transcript encoding the transcription factor RORT, 
which specifies the Th17 lineage. This effect was not observed in T cells co-cultured 
with peritoneal macrophages, and was completely prevented by transwell culture. A 
recent study by Chalmin F et al. uncovered a new Th17 cells subtype characterized by 
the expression of both CD39 and CD73 which display immunosuppressive activity [159]. 
These immunoregulatory Th17 cells were differentiated in vitro in the presence of TGF-
b and IL-6, thus reminiscent of the phenotype acquired by a significant fraction of T cells 
adhering to astrocytes in our co-cultures. Preliminary experiments not reported in the 
thesis addressing the immunosuppressive potential of Th17 cells generated in our 
astrocyte/T cell co-cultures showed pro-inflammatory but not immunoregulatory activity 
of this cell subset, thus suggesting that astrocyte might contribute to priming activated T 
cells for a peculiar brain-specific effector program.   
Finally, the experiments presented in this thesis unravel a so far unknown reciprocal 
signaling between astrocyte and activated CD4+ T cell, which is dependent on cell-cell 
contact and soluble astrocyte released gliotransmitters. Understanding the significance 
of this cross-talk and identifying astrocytes-derived molecules regulating CD4 T cell 
function might unravel new therapeutic targets in MS and other neuroinflammatory 
conditions. 
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